Marilyn Jo Telen
Wellcome Clinical Distinguished Professor of Medicine in Honor of R. Wayne Rundles, M.D.
Dr. Telen is recognized as an expert in the biochemistry and molecular genetics of blood group antigens and the pathophysiological mechanisms of vaso-occlusion in sickle cell disease. She is the Director of the Duke Comprehensive Sickle Cell Center.
Dr. Telen's laboratory focuses on structure/function analysis of membrane proteins expressed by erythroid cells, as well as the role of these proteins in non-erythroid cells. Proteins are also studied in transfectant systems, and research focuses especially on adhesion receptors. The goals of this work are (1) to understand the mechanism and role of red cell adhesion to leukocytes and endothelium in sickle cell disease; (2) to understand the signaling mechanisms leading to activation (and inactivation) of red cell adhesion molecules; (3) to understand the molecular basis of blood group antigen expression, and (4) to understand the interactions of erythroid membrane proteins with other cells and with extracellular matrix..
Recent investigations have focused on the role of signaling pathways in the upregulation of sickle red cell adhesion. Present studies include (1) investigation of beta-adrenergic signaling pathway responsible for activation of B-CAM/LU and LW adhesion receptors; (2) understanding how nitric oxide and ATP downregulate sickle red cell adhesion; (3) studying the effect of these processes in animal models.
Dr. Telen is also involved in a large multicenter study looking for genetic polymorphisms that affect clinical outcomes in sickle cell disease, as well as a multi-center study investigating the mechanisms and treatment of pulmonary hypertension in sickle cell disease.
Key Words:
Adhesion molecules
Erythrocyte membrane
Sickle cell disease
Transfusion medicine
Immunohematology
CD44
B-CAM/LU
Genetic polymorphisms
Dr. Telen's laboratory focuses on structure/function analysis of membrane proteins expressed by erythroid cells, as well as the role of these proteins in non-erythroid cells. Proteins are also studied in transfectant systems, and research focuses especially on adhesion receptors. The goals of this work are (1) to understand the mechanism and role of red cell adhesion to leukocytes and endothelium in sickle cell disease; (2) to understand the signaling mechanisms leading to activation (and inactivation) of red cell adhesion molecules; (3) to understand the molecular basis of blood group antigen expression, and (4) to understand the interactions of erythroid membrane proteins with other cells and with extracellular matrix..
Recent investigations have focused on the role of signaling pathways in the upregulation of sickle red cell adhesion. Present studies include (1) investigation of beta-adrenergic signaling pathway responsible for activation of B-CAM/LU and LW adhesion receptors; (2) understanding how nitric oxide and ATP downregulate sickle red cell adhesion; (3) studying the effect of these processes in animal models.
Dr. Telen is also involved in a large multicenter study looking for genetic polymorphisms that affect clinical outcomes in sickle cell disease, as well as a multi-center study investigating the mechanisms and treatment of pulmonary hypertension in sickle cell disease.
Key Words:
Adhesion molecules
Erythrocyte membrane
Sickle cell disease
Transfusion medicine
Immunohematology
CD44
B-CAM/LU
Genetic polymorphisms
Current Appointments & Affiliations
- Wellcome Clinical Distinguished Professor of Medicine in Honor of R. Wayne Rundles, M.D., Medicine, Hematology, Medicine 2001
- Professor of Medicine, Medicine, Hematology, Medicine 1995
- Associate Professor of Pathology, Pathology, Clinical Science Departments 1996
- Member of the Duke Cancer Institute, Duke Cancer Institute, Institutes and Centers 1980
- Affiliate, Duke Global Health Institute, Duke Global Health Institute, University Institutes and Centers 2018
Contact Information
- 333 Med Sci Res Bldg, Durham, NC 27710
- Duke Box 2615, Durham, NC 27710
-
marilyn.telen@duke.edu
(919) 684-5378
- Background
-
Education, Training, & Certifications
- Fellowship, Hematology/ Oncology, Duke University School of Medicine 1980 - 1983
- Resident, Medicine, State University of New York - Buffalo 1977 - 1980
- Intern, Medicine, State University of New York - Buffalo 1977 - 1978
- M.D., New York University 1977
-
Previous Appointments & Affiliations
- Chief, Division of Hematology in the Department of Medicine, Medicine, Hematology, Medicine 1995 - 2013
- Assistant Professor of Pathology, Pathology, Clinical Science Departments 1994 - 1996
- Associate Professor of Medicine with Tenure, Medicine, Medical Oncology, Medicine 1992 - 1995
- Associate in the Department of Medicine, Medicine, Clinical Science Departments 1983 - 1985
- Recognition
-
In the News
-
SEP 21, 2015 The News & Observer -
SEP 21, 2015 the News & Observer -
MAR 2, 2015
-
-
Awards & Honors
- Expertise
-
Global Scholarship
- Research
-
Selected Grants
- Hematology & Transfusion Medicine (T32) awarded by National Institutes of Health 1975 - 2026
- Randomized double-blind study of FT-4202 in sickle cell disease awarded by FORMA Therapeutics, Inc. 2019 - 2024
- GBT2104-131 A Randomized, Double-blind, Placebo-controlled, Multicenter Study to Assess the Safety and Efficacy of Inclacumab in Participants with Sickle Cell Disease (SCD) Experiencing Vaso-occlusive Crisis (VOCs) awarded by Global Blood Therapeutics, Inc. 2021 - 2024
- Duke CTSA (TL1) Year 5 awarded by National Institutes of Health 2018 - 2023
- Identifying novel clinical, genetic and proteomic risk factors for sickle cell nephropathy. awarded by National Institutes of Health 2021 - 2023
- FORMA FT4202-Hem-301 PRAISE PTV. An Adaptive, Randomized, Placebo-controlled, Double-blind, Multi-center Study of Oral FT-4202, a Pyruvate Kinase Activator in Patients with Sickle Cell Disease (PRAISE). awarded by FORMA Therapeutics, Inc. 2021 - 2023
- A Phase II trial of topical sodium nitrite in patients with sickle cell disease and leg ulcers Cost Reimbursable awarded by Food and Drug Administration 2017 - 2022
- Sickle Cell Disease and CardiovAscular Risk - Red cell Exchange Trial (SCD-CARRE) awarded by University of Pittsburgh 2020 - 2022
- AN OPEN-LABEL EXTENSION STUDY TO EVALUATE THE SAFETY OF RIVIPANSEL (GMI-1070) IN THE TREATMENT OF ONE OR MORE VASOOCCLUSIVE CRISES IN HOSPITALIZED SUBJECTS WITH SICKLE CELL DISEASE awarded by Pfizer, Inc. 2016 - 2021
- CSA - Pfizer 212511 B5201002 Phase 3 Randomized Multicenter Trial awarded by Pfizer, Inc. 2015 - 2021
- Sickle Cell Disease and CardiovAscular Risk - Red cell Exchange Trial (SCD-CARRE) awarded by University of Pittsburgh 2020 - 2021
- Patient Preference Information: Bridging Regulatory Decisions and Clinical Practice awarded by Food and Drug Administration 2018 - 2021
- FORMA Therapeutics FT-4202 awarded by FORMA Therapeutics, Inc. 2019 - 2021
- Multi-site Clinical Laboratory Testing for SickleScan awarded by BioMedomics, Inc. 2017 - 2021
- Sharing Comprehensive 'Omics in Sickle Cell Disease Through the NHLBI TOPMed Network awarded by Doris Duke Charitable Foundation, Inc. 2019 - 2020
- Transcriptomic, therapeutic and genetic investigations of sickle cell nephropathy awarded by National Institutes of Health 2016 - 2020
- Sickle Cell Disease and CardiovAscular Risk - Red cell Exchange Trial (SCD-CARRE) awarded by University of Pittsburgh 2020
- High-throughput Metabolite Profiling and Genetic Analyses to Identify Novel Predictive Biomarkers of SCD-related Complications awarded by Doris Duke Charitable Foundation 2015 - 2020
- Duke-UNC Clinical Hematology and Transfusion Research Career Development Program awarded by National Institutes of Health 2006 - 2019
- Use of Mobile Technology to Improve Acute Care Utilization in Sickle Cell Disease awarded by Agency for Healthcare Research and Quality 2015 - 2018
- Vanderbilt-Emory-Cornell-Duke Consortium for Global Health Fellows (VECDor) awarded by Vanderbilt University 2017 - 2018
- Thalassemia Screening in Myanmese and Lao Migrants in Thailand awarded by Cooley's Anemia Foundation 2017 - 2018
- Factor XIII and Fibrinogen: Mechanisms of Genetic Risk in SCD-Related Priapism awarded by National Institutes of Health 2015 - 2018
- Improving Pain in Sickle Cell Patients With Targeted Antithrombotic Therapy awarded by National Institutes of Health 2014 - 2017
- PFIZER B0401016 awarded by Pfizer, Inc. 2015 - 2017
- Role of RBC NO and ATP in Sickle Vasculopathy awarded by National Institutes of Health 2012 - 2016
- Extension of Hematologic & Clinical Genotype-Phenotype Associations in SCD Using Exome Chip & Metabolomic Analysis awarded by Doris Duke Charitable Foundation 2013 - 2015
- Instrumentation for Quantitative Phosphoproteomics and Acetylomics awarded by National Institutes of Health 2014 - 2015
- Lateral Flow Hemoglobinopathies Test Development awarded by BioMedomics, Inc. 2014
- Impaired release of antiadhesive ATP from stored RBCs: a novel transfusion lesion awarded by National Institutes of Health 2012 - 2014
- Phase II Study of Propranolol as Anti-Adhesive Therapy in SCD awarded by National Institutes of Health 2009 - 2013
- PROPRANOLOL AS ANTI-ADHESIVE THERAPY IN SCD awarded by National Institutes of Health 2010 - 2012
- Duke/UNC Comprehensive Sickle Cell Center awarded by National Institutes of Health 2003 - 2012
- Training in the Genome Sciences and the Hemoglobinopathies awarded by National Institutes of Health 2006 - 2012
- Training in the Genome Sciences and the Hemoglobinopathies awarded by National Institutes of Health 2006 - 2012
- Relationship of Depression to SCD Severity, Health Care Utilization and QoL awarded by Agency for Healthcare Research and Quality 2008 - 2011
- Pulmonary Hypertension in SCD awarded by National Institutes of Health 2005 - 2011
- The Genomic Analysis of Erythrocyte microRNA in Sickle Cell Diseases awarded by National Institutes of Health 2008 - 2011
- Duke-UNC Sickle Cell Disease Clinical Research Network awarded by National Heart, Lung, and Blood Institute 2006 - 2011
- Outcome Modifying Genes in Sickle Cell Diseases awarded by National Institutes of Health 2001 - 2008
- Activation of Sickle Red Cell Adhesion awarded by National Institutes of Health 2003 - 2007
- Adrenergic Receptor Variants and RBC Adhesion in SCD awarded by National Institutes of Health 2004 - 2007
- Minority Invest Post-Bacc Res. Supp. - T Jackson awarded by National Institutes of Health 2001 - 2006
- Factors Involved in B-CAM/LU-Mediated Adhesion awarded by National Institutes of Health 1999 - 2003
- Sickle Cell Adhesion awarded by National Institutes of Health 1997 - 2003
- Transfusion Medicine And Related Areas awarded by National Institutes of Health 1975 - 1999
- Molecular Targets Of The In Lu Gene awarded by National Institutes of Health 1987 - 1997
- Molecular Targets Of The In(Lu) Gene awarded by National Institutes of Health 1993 - 1997
- Molecular Targets Of The In (Lu) Gene awarded by National Institutes of Health 1987 - 1997
- Transfusion Medicine And Related Areas awarded by National Institutes of Health 1975 - 1996
- Transfusion Medicine And Related Areas awarded by National Institutes of Health 1975 - 1996
- Phosphatidylinositol-Anchored Blood Group Antigens awarded by National Institutes of Health 1994 - 1995
- Erythrocyte Protein Antigens Regulated By In-Lu awarded by National Institutes of Health 1992 - 1993
- Erythrocyte Protein Antigens Regulated By In(Lu) awarded by National Institutes of Health 1991 - 1993
- Erythrocyte Protein Antigens Regulated By In(Lu) awarded by National Institutes of Health 1992 - 1993
- Erythrocyte Blood Group Antigens Regulated By In(Lu) awarded by National Institutes of Health 1986 - 1988
- Erythrocyte Blood Group Antigens Regulated By In (Lu) awarded by National Institutes of Health 1985 - 1987
-
External Relationships
- CSL Behring AG
- Forma Therapeutics
- Glycomimetics
- Novartis
- Pfizer Inc.
- Rubius Therapeutics
- Publications & Artistic Works
-
Selected Publications
-
Academic Articles
-
Ataga, Kenneth I., Qingning Zhou, Santosh L. Saraf, Jane S. Hankins, Emily J. Ciccone, Laura R. Loehr, Allison E. Ashley-Koch, et al. “Longitudinal Study of Glomerular Hyperfiltration in Adults with Sickle Cell Anemia: A Multicenter Pooled Analysis.” Blood Adv, June 13, 2022. https://doi.org/10.1182/bloodadvances.2022007693.Full Text Link to Item
-
Liggett, L Alexander, Liam D. Cato, Joshua S. Weinstock, Yingze Zhang, S Mehdi Nouraie, Mark T. Gladwin, Melanie E. Garrett, et al. “Clonal hematopoiesis in sickle cell disease.” J Clin Invest 132, no. 4 (February 15, 2022). https://doi.org/10.1172/JCI156060.Full Text Link to Item
-
Taub, Margaret A., Matthew P. Conomos, Rebecca Keener, Kruthika R. Iyer, Joshua S. Weinstock, Lisa R. Yanek, John Lane, et al. “Genetic determinants of telomere length from 109,122 ancestrally diverse whole-genome sequences in TOPMed.” Cell Genom 2, no. 1 (January 12, 2022). https://doi.org/10.1016/j.xgen.2021.100084.Full Text Link to Item
-
Luo, Yang, Masahiro Kanai, Wanson Choi, Xinyi Li, Saori Sakaue, Kenichi Yamamoto, Kotaro Ogawa, et al. “Author Correction: A high-resolution HLA reference panel capturing global population diversity enables multi-ancestry fine-mapping in HIV host response.” Nat Genet 53, no. 12 (December 2021): 1722. https://doi.org/10.1038/s41588-021-00979-9.Full Text Link to Item
-
Xu, Julia Z., Meghan Foe, Wilaslak Tanongsaksakul, Thidarat Suksangpleng, Supachai Ekwattanakit, Suchada Riolueang, Marilyn J. Telen, Bonnie N. Kaiser, and Vip Viprakasit. “Identification of optimal thalassemia screening strategies for migrant populations in Thailand using a qualitative approach.” Bmc Public Health 21, no. 1 (October 6, 2021): 1796. https://doi.org/10.1186/s12889-021-11831-4.Full Text Link to Item
-
Luo, Yang, Masahiro Kanai, Wanson Choi, Xinyi Li, Saori Sakaue, Kenichi Yamamoto, Kotaro Ogawa, et al. “A high-resolution HLA reference panel capturing global population diversity enables multi-ancestry fine-mapping in HIV host response.” Nat Genet 53, no. 10 (October 2021): 1504–16. https://doi.org/10.1038/s41588-021-00935-7.Full Text Link to Item
-
Cade, Brian E., Jiwon Lee, Tamar Sofer, Heming Wang, Man Zhang, Han Chen, Sina A. Gharib, et al. “Whole-genome association analyses of sleep-disordered breathing phenotypes in the NHLBI TOPMed program.” Genome Med 13, no. 1 (August 26, 2021): 136. https://doi.org/10.1186/s13073-021-00917-8.Full Text Link to Item
-
Xu, Julia Z., Wilaslak Tanongsaksakul, Thidarat Suksangpleng, Supachai Ekwattanakit, Suchada Riolueang, Marilyn J. Telen, and Vip Viprakasit. “Feasibility of and barriers to thalassemia screening in migrant populations: a cross-sectional study of Myanmar and Cambodian migrants in Thailand.” Bmc Public Health 21, no. 1 (June 21, 2021): 1177. https://doi.org/10.1186/s12889-021-11059-2.Full Text Link to Item
-
Keramati, Ali R., Ming-Huei Chen, Benjamin A. T. Rodriguez, Lisa R. Yanek, Arunoday Bhan, Brady J. Gaynor, Kathleen Ryan, et al. “Genome sequencing unveils a regulatory landscape of platelet reactivity.” Nat Commun 12, no. 1 (June 15, 2021): 3626. https://doi.org/10.1038/s41467-021-23470-9.Full Text Link to Item
-
Sofer, Tamar, Xiuwen Zheng, Cecelia A. Laurie, Stephanie M. Gogarten, Jennifer A. Brody, Matthew P. Conomos, Joshua C. Bis, et al. “Variant-specific inflation factors for assessing population stratification at the phenotypic variance level.” Nat Commun 12, no. 1 (June 9, 2021): 3506. https://doi.org/10.1038/s41467-021-23655-2.Full Text Link to Item
-
Ataga, Kenneth I., Qingning Zhou, Vimal K. Derebail, Santosh L. Saraf, Jane S. Hankins, Laura R. Loehr, Melanie E. Garrett, Allison E. Ashley-Koch, Jianwen Cai, and Marilyn J. Telen. “Rapid decline in estimated glomerular filtration rate in sickle cell anemia: results of a multicenter pooled analysis.” Haematologica 106, no. 6 (June 1, 2021): 1749–53. https://doi.org/10.3324/haematol.2020.267419.Full Text Link to Item
-
Natarajan, Pradeep, Akhil Pampana, Sarah E. Graham, Sanni E. Ruotsalainen, James A. Perry, Paul S. de Vries, Jai G. Broome, et al. “Chromosome Xq23 is associated with lower atherogenic lipid concentrations and favorable cardiometabolic indices.” Nat Commun 12, no. 1 (April 12, 2021): 2182. https://doi.org/10.1038/s41467-021-22339-1.Full Text Link to Item
-
Bick, Alexander G., Joshua S. Weinstock, Satish K. Nandakumar, Charles P. Fulco, Erik L. Bao, Seyedeh M. Zekavat, Mindy D. Szeto, et al. “Author Correction: Inherited causes of clonal haematopoiesis in 97,691 whole genomes.” Nature 591, no. 7851 (March 2021): E27. https://doi.org/10.1038/s41586-021-03280-1.Full Text Link to Item
-
Dinardo, Carla L., Theo G. M. Oliveira, Shannon Kelly, Allison Ashley-Koch, Marilyn Telen, Luciana C. Schmidt, Shirley Castilho, et al. “Diversity of variant alleles encoding Kidd, Duffy, and Kell antigens in individuals with sickle cell disease using whole genome sequencing data from the NHLBI TOPMed Program.” Transfusion 61, no. 2 (February 2021): 603–16. https://doi.org/10.1111/trf.16204.Full Text Link to Item
-
Ilboudo, Yann, Melanie E. Garrett, Pablo Bartolucci, Carlo Brugnara, Clary B. Clish, Joel N. Hirschhorn, Frédéric Galactéros, Allison E. Ashley-Koch, Marilyn J. Telen, and Guillaume Lettre. “Potential causal role of l-glutamine in sickle cell disease painful crises: A Mendelian randomization analysis.” Blood Cells Mol Dis 86 (February 2021): 102504. https://doi.org/10.1016/j.bcmd.2020.102504.Full Text Link to Item
-
Taliun, Daniel, Daniel N. Harris, Michael D. Kessler, Jedidiah Carlson, Zachary A. Szpiech, Raul Torres, Sarah A Gagliano Taliun, et al. “Sequencing of 53,831 diverse genomes from the NHLBI TOPMed Program.” Nature 590, no. 7845 (February 2021): 290–99. https://doi.org/10.1038/s41586-021-03205-y.Full Text Link to Item
-
Nielsen, Jonas B., Oren Rom, Ida Surakka, Sarah E. Graham, Wei Zhou, Tanmoy Roychowdhury, Lars G. Fritsche, et al. “Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.” Nat Commun 11, no. 1 (December 18, 2020): 6417. https://doi.org/10.1038/s41467-020-20086-3.Full Text Link to Item
-
Bick, Alexander G., Joshua S. Weinstock, Satish K. Nandakumar, Charles P. Fulco, Erik L. Bao, Seyedeh M. Zekavat, Mindy D. Szeto, et al. “Inherited causes of clonal haematopoiesis in 97,691 whole genomes.” Nature 586, no. 7831 (October 2020): 763–68. https://doi.org/10.1038/s41586-020-2819-2.Full Text Link to Item
-
Telen, Marilyn J. “Pyridoxamine: another vitamin for sickle cell disease?” Haematologica 105, no. 10 (October 1, 2020): 2348–50. https://doi.org/10.3324/haematol.2020.257998.Full Text Link to Item
-
Li, Xihao, Zilin Li, Hufeng Zhou, Sheila M. Gaynor, Yaowu Liu, Han Chen, Ryan Sun, et al. “Dynamic incorporation of multiple in silico functional annotations empowers rare variant association analysis of large whole-genome sequencing studies at scale.” Nat Genet 52, no. 9 (September 2020): 969–83. https://doi.org/10.1038/s41588-020-0676-4.Full Text Link to Item
-
Telen, Marilyn J. “Curative vs targeted therapy for SCD: does it make more sense to address the root cause than target downstream events?” Blood Adv 4, no. 14 (July 28, 2020): 3457–65. https://doi.org/10.1182/bloodadvances.2020001469.Full Text Link to Item
-
Zekavat, Seyedeh M., Sanni Ruotsalainen, Robert E. Handsaker, Maris Alver, Jonathan Bloom, Timothy Poterba, Cotton Seed, et al. “Publisher Correction: Deep coverage whole genome sequences and plasma lipoprotein(a) in individuals of European and African ancestries.” Nat Commun 11, no. 1 (April 1, 2020): 1715. https://doi.org/10.1038/s41467-020-15236-6.Full Text Link to Item
-
Nouraie, Mehdi, Allison E. Ashley-Koch, Melanie E. Garrett, Nithya Sritharan, Yingze Zhang, Jane Little, Victor R. Gordeuk, Mark T. Gladwin, Marilyn J. Telen, and Gregory J. Kato. “Serum albumin is independently associated with higher mortality in adult sickle cell patients: Results of three independent cohorts.” Plos One 15, no. 8 (2020): e0237543. https://doi.org/10.1371/journal.pone.0237543.Full Text Link to Item
-
McMahon, Timothy J., Siqing Shan, Daniel A. Riccio, Milena Batchvarova, Hongmei Zhu, Marilyn J. Telen, and Rahima Zennadi. “Nitric oxide loading reduces sickle red cell adhesion and vaso-occlusion in vivo.” Blood Adv 3, no. 17 (September 10, 2019): 2586–97. https://doi.org/10.1182/bloodadvances.2019031633.Full Text Open Access Copy Link to Item
-
Oyedeji, Charity, John Joseph Strouse, Regina D. Crawford, Melanie E. Garrett, Allison E. Ashley-Koch, and Marilyn J. Telen. “A multi-institutional comparison of younger and older adults with sickle cell disease.” Am J Hematol 94, no. 4 (April 2019): E115–17. https://doi.org/10.1002/ajh.25405.Full Text Link to Item
-
Telen, Marilyn J., Punam Malik, and Gregory M. Vercellotti. “Therapeutic strategies for sickle cell disease: towards a multi-agent approach.” Nat Rev Drug Discov 18, no. 2 (February 2019): 139–58. https://doi.org/10.1038/s41573-018-0003-2.Full Text Link to Item
-
Xu, Julia Z., Melanie E. Garrett, Karen L. Soldano, Sean T. Chen, Clary B. Clish, Allison E. Ashley-Koch, and Marilyn J. Telen. “Clinical and metabolomic risk factors associated with rapid renal function decline in sickle cell disease.” Am J Hematol 93, no. 12 (December 2018): 1451–60. https://doi.org/10.1002/ajh.25263.Full Text Link to Item
-
Ilboudo, Yann, Pablo Bartolucci, Melanie E. Garrett, Allison Ashley-Koch, Marilyn Telen, Carlo Brugnara, Frédéric Galactéros, and Guillaume Lettre. “A common functional PIEZO1 deletion allele associates with red blood cell density in sickle cell disease patients.” Am J Hematol 93, no. 11 (November 2018): E362–65. https://doi.org/10.1002/ajh.25245.Full Text Link to Item
-
Natarajan, Pradeep, Gina M. Peloso, Seyedeh Maryam Zekavat, May Montasser, Andrea Ganna, Mark Chaffin, Amit V. Khera, et al. “Deep-coverage whole genome sequences and blood lipids among 16,324 individuals.” Nat Commun 9, no. 1 (August 23, 2018): 3391. https://doi.org/10.1038/s41467-018-05747-8.Full Text Link to Item
-
Zekavat, Seyedeh M., Sanni Ruotsalainen, Robert E. Handsaker, Maris Alver, Jonathan Bloom, Timothy Poterba, Cotton Seed, et al. “Publisher Correction: Deep coverage whole genome sequences and plasma lipoprotein(a) in individuals of European and African ancestries.” Nat Commun 9, no. 1 (August 23, 2018): 3493. https://doi.org/10.1038/s41467-018-05975-y.Full Text Link to Item
-
Zekavat, Seyedeh M., Sanni Ruotsalainen, Robert E. Handsaker, Maris Alver, Jonathan Bloom, Timothy Poterba, Cotton Seed, et al. “Deep coverage whole genome sequences and plasma lipoprotein(a) in individuals of European and African ancestries.” Nat Commun 9, no. 1 (July 4, 2018): 2606. https://doi.org/10.1038/s41467-018-04668-w.Full Text Link to Item
-
Adam, Soheir S., Charlene M. Flahiff, Shital Kamble, Marilyn J. Telen, Shelby D. Reed, and Laura M. De Castro. “Depression, quality of life, and medical resource utilization in sickle cell disease.” Blood Adv 1, no. 23 (October 24, 2017): 1983–92. https://doi.org/10.1182/bloodadvances.2017006940.Full Text Open Access Copy Link to Item
-
Jacob, Seethal A., Enrico M. Novelli, Jeffrey S. Isenberg, Melanie E. Garrett, Yanxia Chu, Karen Soldano, Kenneth I. Ataga, et al. “Thrombospondin-1 gene polymorphism is associated with estimated pulmonary artery pressure in patients with sickle cell anemia.” Am J Hematol 92, no. 3 (March 2017): E31–34. https://doi.org/10.1002/ajh.24635.Full Text Link to Item
-
Telen, Marilyn J. “Developing new pharmacotherapeutic approaches to treating sickle-cell disease.” Isbt Sci Ser 12, no. 1 (February 2017): 239–47. https://doi.org/10.1111/voxs.12305.Full Text Link to Item
-
Alther, R. A., P. Arndt, D. Bailey, C. Barron, N. Benitez, J. S. Boyd, B. J. Bryant, et al. “Communications: To contributors to the 2017 issues.” Immunohematology 33, no. 4 (January 1, 2017): 173–172.
-
Telen, Marilyn J., Milena Batchvarova, Siqing Shan, Petra H. Bovee-Geurts, Rahima Zennadi, Anna Leitgeb, Roland Brock, and Maria Lindgren. “Sevuparin binds to multiple adhesive ligands and reduces sickle red blood cell-induced vaso-occlusion.” Br J Haematol 175, no. 5 (December 2016): 935–48. https://doi.org/10.1111/bjh.14303.Full Text Link to Item
-
Telen, Marilyn J. “Beyond hydroxyurea: new and old drugs in the pipeline for sickle cell disease.” Blood 127, no. 7 (February 18, 2016): 810–19. https://doi.org/10.1182/blood-2015-09-618553.Full Text Link to Item
-
Doss, Jennifer F., Jude C. Jonassaint, Melanie E. Garrett, Allison E. Ashley-Koch, Marilyn J. Telen, and Jen-Tsan Chi. “Phase 1 Study of a Sulforaphane-Containing Broccoli Sprout Homogenate for Sickle Cell Disease.” Plos One 11, no. 4 (2016): e0152895. https://doi.org/10.1371/journal.pone.0152895.Full Text Link to Item
-
Doss, Jennifer F., David L. Corcoran, Dereje D. Jima, Marilyn J. Telen, Sandeep S. Dave, and Jen-Tsan Chi. “A comprehensive joint analysis of the long and short RNA transcriptomes of human erythrocytes.” Bmc Genomics 16 (November 16, 2015): 952. https://doi.org/10.1186/s12864-015-2156-2.Full Text Link to Item
-
Kanter, Julie, Marilyn J. Telen, Carolyn Hoppe, Christopher L. Roberts, Jason S. Kim, and Xiaoxi Yang. “Validation of a novel point of care testing device for sickle cell disease.” Bmc Med 13 (September 16, 2015): 225. https://doi.org/10.1186/s12916-015-0473-6.Full Text Link to Item
-
Anderson, Blair R., David N. Howell, Karen Soldano, Melanie E. Garrett, Nicholas Katsanis, Marilyn J. Telen, Erica E. Davis, and Allison E. Ashley-Koch. “Correction: In vivo Modeling Implicates APOL1 in Nephropathy: Evidence for Dominant Negative Effects and Epistasis under Anemic Stress.” Plos Genet 11, no. 9 (September 2015): e1005459. https://doi.org/10.1371/journal.pgen.1005459.Full Text Link to Item
-
Anderson, Blair R., David N. Howell, Karen Soldano, Melanie E. Garrett, Nicholas Katsanis, Marilyn J. Telen, Erica E. Davis, and Allison E. Ashley-Koch. “In vivo Modeling Implicates APOL1 in Nephropathy: Evidence for Dominant Negative Effects and Epistasis under Anemic Stress.” Plos Genet 11, no. 7 (July 2015): e1005349. https://doi.org/10.1371/journal.pgen.1005349.Full Text Open Access Copy Link to Item
-
Telen, Marilyn J., Araba Afenyi-Annan, Melanie E. Garrett, Martha R. Combs, Eugene P. Orringer, and Allison E. Ashley-Koch. “Alloimmunization in sickle cell disease: changing antibody specificities and association with chronic pain and decreased survival.” Transfusion 55, no. 6 Pt 2 (June 2015): 1378–87. https://doi.org/10.1111/trf.12940.Full Text Link to Item
-
Telen, Marilyn J., Ted Wun, Timothy L. McCavit, Laura M. De Castro, Lakshmanan Krishnamurti, Sophie Lanzkron, Lewis L. Hsu, et al. “Randomized phase 2 study of GMI-1070 in SCD: reduction in time to resolution of vaso-occlusive events and decreased opioid use.” Blood 125, no. 17 (April 23, 2015): 2656–64. https://doi.org/10.1182/blood-2014-06-583351.Full Text Link to Item
-
Telen, Marilyn J. “Biomarkers and recent advances in the management and therapy of sickle cell disease.” F1000res 4 (2015). https://doi.org/10.12688/f1000research.6615.1.Full Text Link to Item
-
Wun, T., L. Styles, L. DeCastro, M. J. Telen, and F. Kuypers. “Erratum: Phase 1 study of the E-selectin inhibitor GMI 1070 in patients with sickle cell anemia (PLoS ONE (2014) 9, 7 (e101301) DOI:10.1371/journal.pone.0101301).” Plos One 9, no. 10 (October 17, 2014). https://doi.org/10.1371/journal.pone.0111690.Full Text
-
Klings, Elizabeth S., Roberto F. Machado, Claudia R. Morris, Victor R. Gordeuk, Gregory J. Kato, Kenneth I. Ataga, Oswaldo Castro, et al. “Reply: Practice guideline for pulmonary hypertension in sickle cell: direct evidence needed before universal adoption.” Am J Respir Crit Care Med 190, no. 2 (July 15, 2014): 238–40. https://doi.org/10.1164/rccm.201404-0733LE.Full Text Link to Item
-
Elmariah, Hany, Melanie E. Garrett, Laura M. De Castro, Jude C. Jonassaint, Kenneth I. Ataga, James R. Eckman, Allison E. Ashley-Koch, and Marilyn J. Telen. “Factors associated with survival in a contemporary adult sickle cell disease cohort.” Am J Hematol 89, no. 5 (May 2014): 530–35. https://doi.org/10.1002/ajh.23683.Full Text Link to Item
-
Telen, Marilyn J. “Cellular adhesion and the endothelium: E-selectin, L-selectin, and pan-selectin inhibitors.” Hematol Oncol Clin North Am 28, no. 2 (April 2014): 341–54. https://doi.org/10.1016/j.hoc.2013.11.010.Full Text Link to Item
-
Klings, Elizabeth S., Roberto F. Machado, Robyn J. Barst, Claudia R. Morris, Kamal K. Mubarak, Victor R. Gordeuk, Gregory J. Kato, et al. “An official American Thoracic Society clinical practice guideline: diagnosis, risk stratification, and management of pulmonary hypertension of sickle cell disease.” Am J Respir Crit Care Med 189, no. 6 (March 15, 2014): 727–40. https://doi.org/10.1164/rccm.201401-0065ST.Full Text Link to Item
-
Telen, M. J. “Cellular adhesion and the endothelium: E-selectin, L-selectin, and pan-selectin inhibitors.” Hematology/Oncology Clinics of North America 28, no. 2 (2014): 341–54.
-
Telen, Marilyn J. “Teaching evidence-based medicine in the former Soviet Union: lessons learned.” Trans Am Clin Climatol Assoc 125 (2014): 88–102.Link to Item
-
Wun, Ted, Lori Styles, Laura DeCastro, Marilyn J. Telen, Frans Kuypers, Anthony Cheung, William Kramer, et al. “Phase 1 study of the E-selectin inhibitor GMI 1070 in patients with sickle cell anemia.” Plos One 9, no. 7 (2014): e101301. https://doi.org/10.1371/journal.pone.0101301.Full Text Link to Item
-
Galarneau, Geneviève, Sean Coady, Melanie E. Garrett, Neal Jeffries, Mona Puggal, Dina Paltoo, Karen Soldano, et al. “Gene-centric association study of acute chest syndrome and painful crisis in sickle cell disease patients.” Blood 122, no. 3 (July 18, 2013): 434–42. https://doi.org/10.1182/blood-2013-01-478776.Full Text Link to Item
-
Dampier, Carlton D., Wally R. Smith, Carrie G. Wager, Hae-Young Kim, Margaret C. Bell, Scott T. Miller, Debra L. Weiner, et al. “IMPROVE trial: a randomized controlled trial of patient-controlled analgesia for sickle cell painful episodes: rationale, design challenges, initial experience, and recommendations for future studies.” Clin Trials 10, no. 2 (April 2013): 319–31. https://doi.org/10.1177/1740774513475850.Full Text Link to Item
-
Terman, David S., Benjamin L. Viglianti, Rahima Zennadi, Diane Fels, Richard J. Boruta, Hong Yuan, Mathew R. Dreher, et al. “Sickle erythrocytes target cytotoxics to hypoxic tumor microvessels and potentiate a tumoricidal response.” Plos One 8, no. 1 (2013): e52543. https://doi.org/10.1371/journal.pone.0052543.Full Text Open Access Copy Link to Item
-
De Castro, Laura M., Rahima Zennadi, Jude C. Jonassaint, Milena Batchvarova, and Marilyn J. Telen. “Effect of propranolol as antiadhesive therapy in sickle cell disease.” Clin Transl Sci 5, no. 6 (December 2012): 437–44. https://doi.org/10.1111/cts.12005.Full Text Link to Item
-
Shah, Nirmish, Courtney Thornburg, Marilyn J. Telen, and Thomas L. Ortel. “Characterization of the hypercoagulable state in patients with sickle cell disease.” Thromb Res 130, no. 5 (November 2012): e241–45. https://doi.org/10.1016/j.thromres.2012.08.307.Full Text Link to Item
-
Crawford, Regina D., Lindsey Kalhagen, Endi Wang, and Marilyn J. Telen. “Kikuchi-Fugimoto's disease in sickle cell disease: report of 2 cases.” J Natl Med Assoc 104, no. 9–10 (September 2012): 459–62. https://doi.org/10.1016/s0027-9684(15)30201-7.Full Text Link to Item
-
Bae, Harold T., Clinton T. Baldwin, Paola Sebastiani, Marilyn J. Telen, Allison Ashley-Koch, Melanie Garrett, W Craig Hooper, et al. “Meta-analysis of 2040 sickle cell anemia patients: BCL11A and HBS1L-MYB are the major modifiers of HbF in African Americans.” Blood 120, no. 9 (August 30, 2012): 1961–62. https://doi.org/10.1182/blood-2012-06-432849.Full Text Link to Item
-
LaMonte, Gregory, Nisha Philip, Joseph Reardon, Joshua R. Lacsina, William Majoros, Lesley Chapman, Courtney D. Thornburg, et al. “Translocation of sickle cell erythrocyte microRNAs into Plasmodium falciparum inhibits parasite translation and contributes to malaria resistance.” Cell Host Microbe 12, no. 2 (August 16, 2012): 187–99. https://doi.org/10.1016/j.chom.2012.06.007.Full Text Link to Item
-
Telen, M. J. “Mechanisms behind adhesive erythrocytes in sickle-cell disease.” Isbt Science Series 7, no. 1 (July 2012): 197–201. https://doi.org/10.1111/j.1751-2824.2012.01547.x.Full Text
-
Telen, M. J. “GMI-1070: Pan-selectin antagonist treatment of sickle cell disease.” Drugs of the Future 37, no. 6 (June 1, 2012): 403–13. https://doi.org/10.1358/dof.2012.37.6.1790307.Full Text
-
Zennadi, Rahima, Erin J. Whalen, Erik J. Soderblom, Susan C. Alexander, J Will Thompson, Laura G. Dubois, M Arthur Moseley, and Marilyn J. Telen. “Erythrocyte plasma membrane-bound ERK1/2 activation promotes ICAM-4-mediated sickle red cell adhesion to endothelium.” Blood 119, no. 5 (February 2, 2012): 1217–27. https://doi.org/10.1182/blood-2011-03-344440.Full Text Link to Item
-
Milton, Jacqueline N., Paola Sebastiani, Nadia Solovieff, Stephen W. Hartley, Pallav Bhatnagar, Dan E. Arking, Daniel A. Dworkis, et al. “A genome-wide association study of total bilirubin and cholelithiasis risk in sickle cell anemia.” Plos One 7, no. 4 (2012): e34741. https://doi.org/10.1371/journal.pone.0034741.Full Text Link to Item
-
Satterwhite, L. L., N. T. Shaked, D. D. Cyr, M. J. Telen, G. A. Truskey, and A. Wax. “Novel optical signature for sickle cell trait red blood cells.” Frontiers in Optics, Fio 2012, January 1, 2012. https://doi.org/10.1364/fio.2012.fw6a.10.Full Text
-
Telen, M. J. “GMI-1070: Pan-selectin antagonist treatment of sickle cell disease.” Drugs of the Future 37, no. 6 (January 1, 2012): 403–13. https://doi.org/10.1358/dof.2012.037.06.1790307.Full Text
-
Dampier, Carlton D., Wally R. Smith, Hae-Young Kim, Carrie Greene Wager, Margaret C. Bell, Caterina P. Minniti, Jeffrey Keefer, et al. “Opioid patient controlled analgesia use during the initial experience with the IMPROVE PCA trial: a phase III analgesic trial for hospitalized sickle cell patients with painful episodes.” Am J Hematol 86, no. 12 (December 2011): E70–73. https://doi.org/10.1002/ajh.22176.Full Text Link to Item
-
Ashley-Koch, Allison E., Emmanuel C. Okocha, Melanie E. Garrett, Karen Soldano, Laura M. De Castro, Jude C. Jonassaint, Eugene P. Orringer, James R. Eckman, and Marilyn J. Telen. “MYH9 and APOL1 are both associated with sickle cell disease nephropathy.” Br J Haematol 155, no. 3 (November 2011): 386–94. https://doi.org/10.1111/j.1365-2141.2011.08832.x.Full Text Link to Item
-
Zhu, Hongmei, Rahima Zennadi, Bruce X. Xu, Jerry P. Eu, Jordan A. Torok, Marilyn J. Telen, and Timothy J. McMahon. “Impaired adenosine-5'-triphosphate release from red blood cells promotes their adhesion to endothelial cells: a mechanism of hypoxemia after transfusion.” Crit Care Med 39, no. 11 (November 2011): 2478–86. https://doi.org/10.1097/CCM.0b013e318225754f.Full Text Link to Item
-
Dinan, M. A., C. H. Chou, B. G. Hammill, F. L. Graham, K. A. Schulman, M. J. Telen, and S. D. Reed. “Erratum: Outcomes of inpatients with and without sickle cell disease after high-volume surgical procedures.” American Journal of Hematology 86, no. 10 (October 1, 2011): 906–8. https://doi.org/10.1002/ajh.22120.Full Text
-
Kamble, S., M. J. Telen, M. A. Dinan, C. A. Grussemeyer, and S. D. Reed. “Erratum: Costs and length of stay for patients with and without sickle cell disease after hysterectomy, appendectomy, or knee replacement.” American Journal of Hematology 86, no. 10 (October 1, 2011): 903. https://doi.org/10.1002/ajh.22121.Full Text
-
Burnette, Angela D., Shahid M. Nimjee, Milena Batchvarova, Rahima Zennadi, Marilyn J. Telen, Jun-Ichi Nishimura, and Bruce A. Sullenger. “RNA aptamer therapy for vaso-occlusion in sickle cell disease.” Nucleic Acid Ther 21, no. 4 (August 2011): 275–83. https://doi.org/10.1089/nat.2010.0270.Full Text Link to Item
-
Shah, Nirmish, Marilyn J. Telen, and Thomas L. Ortel. “Comparison of thrombin generation of sickle cell patients in crisis and steady state using the thrombin generation assay (TGA).” Haemophilia 17, no. 3 (May 1, 2011): 557–557.Link to Item
-
Shaked, Natan T., Lisa L. Satterwhite, Marilyn J. Telen, George A. Truskey, and Adam Wax. “Quantitative microscopy and nanoscopy of sickle red blood cells performed by wide field digital interferometry.” J Biomed Opt 16, no. 3 (March 2011): 030506. https://doi.org/10.1117/1.3556717.Full Text Link to Item
-
Wang, Winfred, Carlo Brugnara, Cathie Snyder, Lynn Wynn, Zora Rogers, Karen Kalinyak, Clark Brown, et al. “The effects of hydroxycarbamide and magnesium on haemoglobin SC disease: results of the multi-centre CHAMPS trial.” Br J Haematol 152, no. 6 (March 2011): 771–76. https://doi.org/10.1111/j.1365-2141.2010.08523.x.Full Text Link to Item
-
Zhu, H., R. Zennadi, B. Xu, J. P. Eu, J. Torok, M. J. Telen, and T. J. McMahon. “Red Blood Cell Release Of ATP Prevents Endothelial Adhesion: Implications For Post-Transfusion Lung Dysfunction.” American Journal of Respiratory and Critical Care Medicine 183 (January 1, 2011).Link to Item
-
Sangokoya, Carolyn, Marilyn J. Telen, and Jen-Tsan Chi. “microRNA miR-144 modulates oxidative stress tolerance and associates with anemia severity in sickle cell disease.” Blood 116, no. 20 (November 18, 2010): 4338–48. https://doi.org/10.1182/blood-2009-04-214817.Full Text Link to Item
-
Adam, S. S., M. J. Telen, C. R. Jonassaint, L. M. De Castro, and J. C. Jonassaint. “The relationship of opioid analgesia to quality of life in an adult sickle cell population.” Health Outcomes Research in Medicine 1, no. 1 (July 1, 2010). https://doi.org/10.1016/j.ehrm.2010.04.002.Full Text
-
Brittain, Julia E., Ben Hulkower, Susan K. Jones, Dell Strayhorn, Laura De Castro, Marilyn J. Telen, Eugene P. Orringer, Alan Hinderliter, and Kenneth I. Ataga. “Placenta growth factor in sickle cell disease: association with hemolysis and inflammation.” Blood 115, no. 10 (March 11, 2010): 2014–20. https://doi.org/10.1182/blood-2009-04-217950.Full Text Link to Item
-
Stamler, J. S., and M. J. Telen. “Functions of Blood Group Antigens,” March 10, 2010, 276–86. https://doi.org/10.1002/9781444318531.ch22.Full Text
-
Solovieff, Nadia, Jacqueline N. Milton, Stephen W. Hartley, Richard Sherva, Paola Sebastiani, Daniel A. Dworkis, Elizabeth S. Klings, et al. “Fetal hemoglobin in sickle cell anemia: genome-wide association studies suggest a regulatory region in the 5' olfactory receptor gene cluster.” Blood 115, no. 9 (March 4, 2010): 1815–22. https://doi.org/10.1182/blood-2009-08-239517.Full Text Link to Item
-
Thornburg, Courtney D., Agustin Calatroni, Marilyn Telen, and Alex R. Kemper. “Adherence to hydroxyurea therapy in children with sickle cell anemia.” J Pediatr 156, no. 3 (March 2010): 415–19. https://doi.org/10.1016/j.jpeds.2009.09.044.Full Text Link to Item
-
Slichter, Sherrill J., Richard M. Kaufman, Susan F. Assmann, Jeffrey McCullough, Darrell J. Triulzi, Ronald G. Strauss, Terry B. Gernsheimer, et al. “Dose of prophylactic platelet transfusions and prevention of hemorrhage.” N Engl J Med 362, no. 7 (February 18, 2010): 600–613. https://doi.org/10.1056/NEJMoa0904084.Full Text Link to Item
-
Ballas, Samir K., Susan Lieff, Lennette J. Benjamin, Carlton D. Dampier, Matthew M. Heeney, Carolyn Hoppe, Cage S. Johnson, et al. “Definitions of the phenotypic manifestations of sickle cell disease.” Am J Hematol 85, no. 1 (January 2010): 6–13. https://doi.org/10.1002/ajh.21550.Full Text Link to Item
-
Fitzhugh, Courtney D., Naudia Lauder, Jude C. Jonassaint, Marilyn J. Telen, Xiongce Zhao, Elizabeth C. Wright, Francis R. Gilliam, and Laura M. De Castro. “Cardiopulmonary complications leading to premature deaths in adult patients with sickle cell disease.” Am J Hematol 85, no. 1 (January 2010): 36–40. https://doi.org/10.1002/ajh.21569.Full Text Link to Item
-
Kamble, Shital, Marilyn J. Telen, Michaela A. Dinan, Chelsea A. Grussemeyer, and Shelby D. Reed. “Costs and length of stay for patients with and without sickle cell disease after hysterectomy, appendectomy, or knee replacement.” Am J Hematol 85, no. 1 (January 2010): 79–81. https://doi.org/10.1002/ajh.21576.Full Text Link to Item
-
Sebastiani, Paola, Nadia Solovieff, Stephen W. Hartley, Jacqueline N. Milton, Alberto Riva, Daniel A. Dworkis, Efthymia Melista, et al. “Genetic modifiers of the severity of sickle cell anemia identified through a genome-wide association study.” Am J Hematol 85, no. 1 (January 2010): 29–35. https://doi.org/10.1002/ajh.21572.Full Text Link to Item
-
Dinan, Michaela A., Chia-Hung Chou, Bradley G. Hammill, Felicia L. Graham, Kevin A. Schulman, Marilyn J. Telen, and Shelby D. Reed. “Outcomes of inpatients with and without sickle cell disease after high-volume surgical procedures.” Am J Hematol 84, no. 11 (November 2009): 703–9. https://doi.org/10.1002/ajh.21520.Full Text Link to Item
-
Afenyi-Annan, Araba, Allison Ashley-Koch, and Marilyn J. Telen. “Duffy (Fy), DARC, and neutropenia among women from the United States, Europe and the Caribbean.” Br J Haematol 145, no. 2 (April 2009): 266–67. https://doi.org/10.1111/j.1365-2141.2009.07588.x.Full Text Link to Item
-
Adam, Soheir S., Jude C. Jonassaint, Mary R. Abrams, Charles R. Jonassaint, Marilyn J. Telen, and Laura M. De Castro. “Obstetric and Gynecological History in Sickle Cell Disease Females.” Blood 112, no. 11 (November 16, 2008): 867–68.Link to Item
-
Jonassaint, Jude C., Charles R. Jonassaint, Charlene M. Flahiff, Andrea Ball, Soheir S. Adam, Marilyn J. Telen, and Laura M. De Castro. “Does Living Closer to a Medical Care Center Matter in Sickle Cell Disease?” Blood 112, no. 11 (November 16, 2008): 323–24.Link to Item
-
Silbermins, Damian, Laura M. De Castro, Allison E. Ashley-Koch, Jude C. Jonassaint, Melanie E. Garrett, James R. Eckman, Eugene P. Orringer, and Marilyn J. Telen. “Prolonged Survival despite High Disease Burden in Elderly (>= 55) Patients with Hb SS or Hb S beta 0 Thalassemia.” Blood 112, no. 11 (November 16, 2008): 264–264.Link to Item
-
Silbermins, Damian, Laura M. De Castro, Jude C. Jonassaint, Shiaowen David Hsu, Marilyn J. Telen, and Jen-Tsam Chi. “Genomic Approaches to Identifying Risk for Pulmonary Artery Hypertension among Individuals with Sickle Cell Disease.” Blood 112, no. 11 (November 16, 2008): 514–514.Link to Item
-
Telen, Marilyn J., Martha Delahunty, Cathie Snyder, and Winfred C. Wang. “Erythrocyte Adhesion and Phosphatidylserine Exposure in HbSC Disease: Baseline Data from the CHAMPS Study.” Blood 112, no. 11 (November 16, 2008): 861–861.Link to Item
-
Thornburg, Courtney D., Agustin Calatroni, Brittany Herzberg, Marilyn J. Telen, and Alex Kemper. “Adherence with Hydroxyurea in Children with Sickle Cell Disease.” Blood 112, no. 11 (November 16, 2008): 69–69.Link to Item
-
Zennadi, Rahima, Ai Chien, Ke Xu, Milena Batchvarova, and Marilyn J. Telen. “Sickle red cells induce adhesion of lymphocytes and monocytes to endothelium.” Blood 112, no. 8 (October 15, 2008): 3474–83. https://doi.org/10.1182/blood-2008-01-134346.Full Text Link to Item
-
Adam, Soheir, Jude Jonassaint, Hillary Kruger, Melanie Kail, Eugene P. Orringer, James R. Eckman, Allison Ashley-Koch, Marilyn J. Telen, and Laura M. De Castro. “Surgical and obstetric outcomes in adults with sickle cell disease.” Am J Med 121, no. 10 (October 2008): 916–21. https://doi.org/10.1016/j.amjmed.2008.04.040.Full Text Link to Item
-
Telen, Marilyn J. “It really IS the red cell.” Blood 112, no. 3 (August 1, 2008): 459–60. https://doi.org/10.1182/blood-2008-05-155754.Full Text Link to Item
-
Ashley-Koch, Allison E., Laine Elliott, Melanie E. Kail, Laura M. De Castro, Jude Jonassaint, Terry L. Jackson, Jennifer Price, et al. “Identification of genetic polymorphisms associated with risk for pulmonary hypertension in sickle cell disease.” Blood 111, no. 12 (June 15, 2008): 5721–26. https://doi.org/10.1182/blood-2007-02-074849.Full Text Link to Item
-
Chen, Shao-Yin, Yulei Wang, Marilyn J. Telen, and Jen-Tsan Chi. “The genomic analysis of erythrocyte microRNA expression in sickle cell diseases.” Plos One 3, no. 6 (June 4, 2008): e2360. https://doi.org/10.1371/journal.pone.0002360.Full Text Open Access Copy Link to Item
-
Afenyi-Annan, Araba, Melanie Kail, Martha R. Combs, Eugene P. Orringer, Allison Ashley-Koch, and Marilyn J. Telen. “Lack of Duffy antigen expression is associated with organ damage in patients with sickle cell disease.” Transfusion 48, no. 5 (May 2008): 917–24. https://doi.org/10.1111/j.1537-2995.2007.01622.x.Full Text Link to Item
-
Eyler, Christine E., Terry Jackson, Laine E. Elliott, Laura M. De Castro, Jude Jonassaint, Allison Ashley-Koch, and Marilyn J. Telen. “beta(2)-Adrenergic receptor and adenylate cyclase gene polymorphisms affect sickle red cell adhesion.” Br J Haematol 141, no. 1 (April 2008): 105–8. https://doi.org/10.1111/j.1365-2141.2008.07008.x.Full Text Link to Item
-
Johnson, Clarissa, and Marilyn J. Telen. “Adhesion molecules and hydroxyurea in the pathophysiology of sickle cell disease.” Haematologica 93, no. 4 (April 2008): 481–85. https://doi.org/10.3324/haematol.12734.Full Text Link to Item
-
Zennadi, R., L. De Castro, C. Eyler, K. Xu, M. Ko, and M. J. Telen. “Role and regulation of sickle red cell interactions with other cells: ICAM-4 and other adhesion receptors.” Transfus Clin Biol 15, no. 1–2 (February 2008): 23–28. https://doi.org/10.1016/j.tracli.2008.04.009.Full Text Link to Item
-
De Castro, Laura M., Jude C. Jonassaint, Felicia L. Graham, Allison Ashley-Koch, and Marilyn J. Telen. “Pulmonary hypertension associated with sickle cell disease: clinical and laboratory endpoints and disease outcomes.” Am J Hematol 83, no. 1 (January 2008): 19–25. https://doi.org/10.1002/ajh.21058.Full Text Link to Item
-
Horwitz, Mitchell E., Ivan Spasojevic, Ashley Morris, Marilyn Telen, James Essell, Cristina Gasparetto, Keith Sullivan, et al. “Fludarabine-based nonmyeloablative stem cell transplantation for sickle cell disease with and without renal failure: clinical outcome and pharmacokinetics.” Biol Blood Marrow Transplant 13, no. 12 (December 2007): 1422–26. https://doi.org/10.1016/j.bbmt.2007.08.050.Full Text Link to Item
-
Bennett-Guerrero, Elliott, Tim H. Veldman, Allan Doctor, Marilyn J. Telen, Thomas L. Ortel, T Scott Reid, Melissa A. Mulherin, et al. “Evolution of adverse changes in stored RBCs.” Proc Natl Acad Sci U S A 104, no. 43 (October 23, 2007): 17063–68. https://doi.org/10.1073/pnas.0708160104.Full Text Link to Item
-
Zennadi, Rahima, Benjamin J. Moeller, Erin J. Whalen, Milena Batchvarova, Ke Xu, Siqing Shan, Martha Delahunty, Mark W. Dewhirst, and Marilyn J. Telen. “Epinephrine-induced activation of LW-mediated sickle cell adhesion and vaso-occlusion in vivo.” Blood 110, no. 7 (October 1, 2007): 2708–17. https://doi.org/10.1182/blood-2006-11-056101.Full Text Link to Item
-
Chou, C. H., S. D. Reed, M. J. Telen, and K. A. Schulman. “PHM1 A COMPARISON OF INPATIENT OUTCOMES BETWEEN SICKLE CELL DISEASE AND NON-SICKLE CELL DISEASE PATIENTS UNDERGOING HIGH-VOLUME SURGICAL PROCEDURES.” Value in Health 10, no. 3 (May 2007): A152–53. https://doi.org/10.1016/s1098-3015(10)69001-8.Full Text
-
Elliott, Laine, Allison E. Ashley-Koch, Laura De Castro, Jude Jonassaint, Jennifer Price, Kenneth I. Ataga, Marc C. Levesque, et al. “Genetic polymorphisms associated with priapism in sickle cell disease.” Br J Haematol 137, no. 3 (May 2007): 262–67. https://doi.org/10.1111/j.1365-2141.2007.06560.x.Full Text Link to Item
-
Nishimura, Jun-ichi, Marilyn J. Telen, and Bruce A. Sullenger. “Innovative Drug Design Using RNA Aptamers for Various Anemias.” Oncology &Amp; Hematology Review (Us) 00, no. 01 (2007): 55–55. https://doi.org/10.17925/ohr.2007.01.01.55.Full Text
-
Telen, Marilyn J. “Role of adhesion molecules and vascular endothelium in the pathogenesis of sickle cell disease.” Hematology Am Soc Hematol Educ Program, 2007, 84–90. https://doi.org/10.1182/asheducation-2007.1.84.Full Text Link to Item
-
Elliott, Laine, Allison E. Ashley-Koch, Jude Jonassaint, Jennifer Price, Jason Galloway, Kenneth I. Ataga, Marc C. Levesque, et al. “Genetic polymorphisms associated with priapism in sickle cell disease.” Blood 108, no. 11 (November 16, 2006): 236A-237A.Link to Item
-
Nishimura, Jun-Ichi, Angela D. Burnette, Milena Batchvarova, Shahid M. Nimjee, Rahima Zennadi, Bruce A. Sullenger, and Marilyn J. Telen. “Blocking adhesion of sickle erythrocytes to endothelial alpha V beta 3 using RNA aptamer.” Blood 108, no. 11 (November 16, 2006): 206A-207A.Link to Item
-
Engelfriet, C. P., H. W. Reesink, R. Fontão-Wendel, A. Lazar, R. A. Cardoso, S. Olyntho, R. Achkar, et al. “Prevention and diagnosis of delayed haemolytic transfusion reactions.” Vox Sang 91, no. 4 (November 2006): 353–68. https://doi.org/10.1111/j.1423-0410.2006.00812_1.x.Full Text Link to Item
-
Fontão-Wendel, R., A. Lazar, R. A. Cardoso, S. Olyntho, R. Achkar, S. Wendel, M. Pisacka, et al. “Prevention and diagnosis of delayed haemolytic transfusion reactions.” Vox Sanguinis 91, no. 4 (November 2006): 353–68. https://doi.org/10.1111/j.1423-0410.2006.00812.x.Full Text
-
Snell, M., C. Chau, D. Hendrix, R. Fox, K. A. Downes, R. Creger, H. Meyerson, et al. “Lack of isohemagglutinin production following minor ABO incompatible unrelated HLA mismatched umbilical cord blood transplantation.” Bone Marrow Transplant 38, no. 2 (July 2006): 135–40. https://doi.org/10.1038/sj.bmt.1705409.Full Text Link to Item
-
Eyler, Christine E., and Marilyn J. Telen. “The Lutheran glycoprotein: a multifunctional adhesion receptor.” Transfusion 46, no. 4 (April 2006): 668–77. https://doi.org/10.1111/j.1537-2995.2006.00779.x.Full Text Link to Item
-
Delahunty, M., R. Zennadi, and M. J. Telen. “LW protein: a promiscuous integrin receptor activated by adrenergic signaling.” Transfus Clin Biol 13, no. 1–2 (March 2006): 44–49. https://doi.org/10.1016/j.tracli.2006.02.022.Full Text Link to Item
-
Itakura, H., M. J. Telen, C. C. Hoppe, D. A. E. White, and J. L. Zehnder. “Characterization of a novel prothrombin variant, Prothrombin C20209T, as a modifier of thrombotic risk among African-Americans.” J Thromb Haemost 3, no. 10 (October 2005): 2357–59. https://doi.org/10.1111/j.1538-7836.2005.01562.x.Full Text Link to Item
-
Wanko, Sam O., and Marilyn J. Telen. “Transfusion management in sickle cell disease.” Hematol Oncol Clin North Am 19, no. 5 (October 2005): 803–vi. https://doi.org/10.1016/j.hoc.2005.07.002.Full Text Link to Item
-
Murphy, Meghan M., Mohamed A. Zayed, Allyson Evans, Carol E. Parker, Kenneth I. Ataga, Marilyn J. Telen, and Leslie V. Parise. “Role of Rap1 in promoting sickle red blood cell adhesion to laminin via BCAM/LU.” Blood 105, no. 8 (April 15, 2005): 3322–29. https://doi.org/10.1182/blood-2004-07-2881.Full Text Link to Item
-
Telen, Marilyn J. “Erythrocyte adhesion receptors: blood group antigens and related molecules.” Transfus Med Rev 19, no. 1 (January 2005): 32–44. https://doi.org/10.1016/j.tmrv.2004.09.006.Full Text Link to Item
-
Zennadi, Rahima, Patrick C. Hines, Laura M. De Castro, Jean-Pierre Cartron, Leslie V. Parise, and Marilyn J. Telen. “Epinephrine acts through erythroid signaling pathways to activate sickle cell adhesion to endothelium via LW-alphavbeta3 interactions.” Blood 104, no. 12 (December 1, 2004): 3774–81. https://doi.org/10.1182/blood-2004-01-0042.Full Text Link to Item
-
Drewniok, Claudia, B Gregor Wienrich, Margarete Schön, Jens Ulrich, Qin Zen, Marilyn J. Telen, Roland J. Hartig, Ilse Wieland, Harald Gollnick, and Michael P. Schön. “Molecular interactions of B-CAM (basal-cell adhesion molecule) and laminin in epithelial skin cancer.” Arch Dermatol Res 296, no. 2 (July 2004): 59–66. https://doi.org/10.1007/s00403-004-0481-4.Full Text Link to Item
-
Zen, Qin, Milena Batchvarova, Christina A. Twyman, Christine E. Eyler, Huiling Qiu, Laura M. De Castro, and Marilyn J. Telen. “B-CAM/LU expression and the role of B-CAM/LU activation in binding of low- and high-density red cells to laminin in sickle cell disease.” Am J Hematol 75, no. 2 (February 2004): 63–72. https://doi.org/10.1002/ajh.10442.Full Text Link to Item
-
Hines, Patrick C., Qin Zen, Sharran N. Burney, Deborah A. Shea, Kenneth I. Ataga, Eugene P. Orringer, Marilyn J. Telen, and Leslie V. Parise. “Novel epinephrine and cyclic AMP-mediated activation of BCAM/Lu-dependent sickle (SS) RBC adhesion.” Blood 101, no. 8 (April 15, 2003): 3281–87. https://doi.org/10.1182/blood-2001-12-0289.Full Text Link to Item
-
Parise, Leslie V., and Marilyn J. Telen. “Erythrocyte adhesion in sickle cell disease.” Curr Hematol Rep 2, no. 2 (March 2003): 102–8.Link to Item
-
Kypson, Alan P., John J. Warner, Marilyn J. Telen, and Carmelo A. Milano. “Paroxysmal cold hemoglobinuria and cardiopulmonary bypass.” Ann Thorac Surg 75, no. 2 (February 2003): 579–81. https://doi.org/10.1016/s0003-4975(02)04337-0.Full Text Link to Item
-
Garratty, George, Marilyn J. Telen, and Lawrence D. Petz. “Red cell antigens as functional molecules and obstacles to transfusion.” Hematology Am Soc Hematol Educ Program, 2002, 445–62. https://doi.org/10.1182/asheducation-2002.1.445.Full Text Link to Item
-
Zen, Q., C. A. Twyman, and M. J. Telen. “Sickle red cell B-CAM/LU mediates adhesion to multiple sites of laminin under different conditions.” Blood 98, no. 11 (November 16, 2001): 484A-485A.Link to Item
-
Zennadi, R., and M. J. Telen. “Red cell signaling pathways cause increased sickle cell adhesion to non-activated endothelial cells.” Blood 98, no. 11 (November 16, 2001): 484A-484A.Link to Item
-
Telen, M. J. “Principles and problems of transfusion in sickle cell disease.” Semin Hematol 38, no. 4 (October 2001): 315–23. https://doi.org/10.1016/s0037-1963(01)90025-3.Full Text Link to Item
-
Combs, M. R., B. Jewett-Keefe, and M. J. Telen. “An unusual Rh antibody apparently reactive with an epitope encoded by RHD exon 2.” Transfusion 41, no. 9 (September 1, 2001): 10S-10S.Link to Item
-
Combs, M. R., D. Eveland, B. Jewett-Keefe, and M. J. Telen. “The use of polyethylene glycol in adsorptions: More evidence that antibodies may be missed.” Transfusion 41, no. 9 (September 1, 2001): 30S-30S.Link to Item
-
Jewett-Keefe, B., M. R. Combs, and M. J. Telen. “Antibodies exhibiting dosage in gel.” Transfusion 41, no. 9 (September 1, 2001): 107S-107S.Link to Item
-
Lee, S., D. C. Russo, A. P. Reiner, J. H. Lee, M. Y. Sy, M. J. Telen, W. J. Judd, et al. “Molecular defects underlying the Kell null phenotype.” J Biol Chem 276, no. 29 (July 20, 2001): 27281–89. https://doi.org/10.1074/jbc.M103433200.Full Text Link to Item
-
Combs, M. R., D. H. Bennett, and M. J. Telen. “Re: Use of red blood cell units containing alloantibodies [1].” Immunohematology 17, no. 2 (January 1, 2001): 58. https://doi.org/10.21307/IMMUNOHEMATOLOGY-2019-548.Full Text
-
Staley, J. C., M. R. Combs, D. H. Bennett, and M. J. Telen. “Use of red blood cell units containing alloantibodies (multiple letters).” Immunohematology 17, no. 2 (January 1, 2001): 58.
-
Lin, W. C., and M. J. Telen. “Cardiac metastasis from a transitional cell carcinoma: a case report.” Med Oncol 17, no. 2 (May 2000): 147–50. https://doi.org/10.1007/BF02796211.Full Text Link to Item
-
Telen, M. J. “Red blood cell surface adhesion molecules: their possible roles in normal human physiology and disease.” Semin Hematol 37, no. 2 (April 2000): 130–42. https://doi.org/10.1016/s0037-1963(00)90038-6.Full Text Link to Item
-
Combs, M. R., D. H. Bennett, and M. J. Telen. “Large-scale use of red blood cell units containing alloantibodies.” Immunohematology 16, no. 3 (2000): 120–23.Link to Item
-
Zen, Q., C. A. Twyman, and M. J. Telen. “Laminin binding and B-CAM/LU expression by high and low density reticulocytes vs mature red cells in sickle cell disease.” Blood 94, no. 10 (November 15, 1999): 675A-675A.Link to Item
-
Telen, M. J., and M. Combs. “Management of massive delayed hemolytic transfusion reactions in patients with sickle cell disease.” Transfusion 39, no. 10 (October 1, 1999): 97S-97S.Link to Item
-
ALI, M. “Wendell Rosse, Marilyn Telen and Russell Ware, Transfusion Support for Patients With Sickle Cell Disease, AABB Press, Bethesda, MD (1998) 105 pages. Softcover.” Transfusion Medicine Reviews 13, no. 3 (July 1999): 235–235. https://doi.org/10.1016/s0887-7963(99)80036-4.Full Text
-
Zen, Q., M. E. Riddle, A. M. Fong, D. D. Patel, D. M. Paulsen, G. Truskey, and M. J. Telen. “Identification and characterization of another non-integrin IgSF membrane protein receptor for laminin.” Faseb Journal 13, no. 7 (April 23, 1999): A1360–A1360.Link to Item
-
Zen, Q., M. Cottman, G. Truskey, R. Fraser, and M. J. Telen. “Critical factors in basal cell adhesion molecule/lutheran-mediated adhesion to laminin.” J Biol Chem 274, no. 2 (January 8, 1999): 728–34. https://doi.org/10.1074/jbc.274.2.728.Full Text Link to Item
-
Telen, M. J., G. Harris, and E. Whitworth. “Caring for patients with sickle cell disease in North Carolina.” N C Med J 60, no. 1 (January 1999): 14–17.Link to Item
-
Combs, M. R., D. H. Bennett, and M. J. Telen. “Large-scale use of red blood cell units containing alloantibodies.” Transfusion 38, no. 10 (October 1, 1998): 69S-69S.Link to Item
-
Udani, M., Q. Zen, M. Cottman, N. Leonard, S. Jefferson, C. Daymont, G. Truskey, and M. J. Telen. “Basal cell adhesion molecule Lutheran protein - The receptor critical for sickle cell adhesion to laminin (vol 101, pg 2550, 1998).” Journal of Clinical Investigation 102, no. 1 (July 1, 1998): 271–271.Link to Item
-
Udani, M., Q. Zen, M. Cottman, N. Leonard, S. Jefferson, C. Daymont, G. Truskey, and M. J. Telen. “Erratum: (The Journal of Clinical Investigation (June 1998) 101:11 (2550-2558)).” Journal of Clinical Investigation 102, no. 1 (July 1, 1998): 269.
-
Udani, M., Q. Zen, M. Cottman, N. Leonard, S. Jefferson, C. Daymont, G. Truskey, and M. J. Telen. “Basal cell adhesion molecule/lutheran protein. The receptor critical for sickle cell adhesion to laminin.” J Clin Invest 101, no. 11 (June 1, 1998): 2550–58. https://doi.org/10.1172/JCI1204.Full Text Link to Item
-
Zen, Q., M. Udani, M. Cottman, R. Fraser, G. Truskey, and M. J. Telen. “B-CAM/LU protein: A single IgSF domain and copy number but not the cytoplasmic region are critical for laminin binding.” Blood 90, no. 10 (November 15, 1997): 2685–2685.Link to Item
-
Udani, M., N. Rao, and M. J. Telen. “Leukocyte phenotypic changes in an in vitro model of ABO hemolytic transfusion reaction.” Transfusion 37, no. 9 (September 1997): 904–9. https://doi.org/10.1046/j.1537-2995.1997.37997454015.x.Full Text Link to Item
-
Washington, K., M. J. Telen, and M. R. Gottfried. “Expression of cell adhesion molecule CD44 in primary tumors of the liver: an immunohistochemical study.” Liver 17, no. 1 (February 1997): 17–23. https://doi.org/10.1111/j.1600-0676.1997.tb00773.x.Full Text Link to Item
-
Telen, M. J. “Coordinator's report--section 2D3.” Transfus Clin Biol 4, no. 1 (1997): 137–38. https://doi.org/10.1016/s1246-7820(97)80029-8.Full Text Link to Item
-
Udani, M., S. Jefferson, C. Daymont, Q. Zen, and M. J. Telen. “BCAM/LU protein: A novel laminin receptor overexpressed by sickle erythrocytes.” Blood 88, no. 10 (November 15, 1996): 13–13.Link to Item
-
Mudad, R., and M. J. Telen. “Biologic functions of blood group antigens.” Curr Opin Hematol 3, no. 6 (November 1996): 473–79. https://doi.org/10.1097/00062752-199603060-00013.Full Text Link to Item
-
Telen, M. J. “Erythrocyte blood group antigens: polymorphisms of functionally important molecules.” Semin Hematol 33, no. 4 (October 1996): 302–14.Link to Item
-
Cobourn, S. D., and M. J. Telen. “Erythroid-specific regulation of the CD44 in antigen gene promoter.” Transfusion 36, no. 9 (September 1, 1996): S189–S189.Link to Item
-
Zervos, F. C., R. Katz, M. Udani, and M. J. Telen. “Expression of human blood group antigens by human and murine cell lines.” Transfusion 36, no. 9 (September 1, 1996): S190–S190.Link to Item
-
Telen, M. J., M. Udani, M. K. Washington, M. C. Levesque, E. Lloyd, and N. Rao. “A blood group-related polymorphism of CD44 abolishes a hyaluronan-binding consensus sequence without preventing hyaluronan binding.” J Biol Chem 271, no. 12 (March 22, 1996): 7147–53. https://doi.org/10.1074/jbc.271.12.7147.Full Text Link to Item
-
Issitt, P. D., and M. J. Telen. “D, weak D (Du), and partial D: the molecular story unfolds.” Transfusion 36, no. 2 (February 1996): 97–100. https://doi.org/10.1046/j.1537-2995.1996.36296181917.x.Full Text Link to Item
-
Udani, M., N. Rao, S. Cobourn, J. Licker, J. Kurtzberg, and M. J. Telen. “Erythroid progenitors express a CD44 variant with reduced hyaluronic acid binding ability and reduced expression of the epitope associated with Hemophilus influenzae hemagglutination.” Blood 86, no. 10 (November 15, 1995): 1876–1876.Link to Item
-
Udani, M., N. Rao, and M. J. Telen. “Modulation of hyaluronan binding to CD44H.” Blood 86, no. 10 (November 15, 1995): 1877–1877.Link to Item
-
Mudad, R., N. Rao, P. D. Issitt, R. B. Roy, M. R. Combs, and M. J. Telen. “JMH variants: serologic, clinical, and biochemical analyses in two cases.” Transfusion 35, no. 11 (November 1995): 925–30. https://doi.org/10.1046/j.1537-2995.1995.351196110897.x.Full Text Link to Item
-
Telen, M. J. “Clinical problem-solving: costly errors.” N Engl J Med 333, no. 16 (October 19, 1995): 1080–81.Link to Item
-
ISSITT, P. D., M. R. COMBS, R. MUDAD, and M. J. TELEN. “AN ANTI-JMH CAUSING IN-VIVO RED-CELL DESTRUCTION.” Transfusion 35, no. 10 (October 1, 1995): S86–S86.Link to Item
-
TELEN, M. J., J. NELSON, N. ANDERSON, C. KAPLAN, and M. UDANI. “ACANTHOCYTOSIS ASSOCIATED WITH PARTIAL CD44 DEFICIENCY.” Transfusion 35, no. 10 (October 1, 1995): S238–S238.Link to Item
-
UDANI, M., N. RAO, and M. J. TELEN. “LEUKOCYTE PHENOTYPIC CHANGES IN AN IN-VITRO MODEL OF ABO HEMOLYTIC TRANSFUSION REACTION.” Transfusion 35, no. 10 (October 1, 1995): S185–S185.Link to Item
-
UDANI, M., N. RAO, and M. J. TELEN. “DOMBROCK PROTEIN - A MONOCYTE ACTIVATION MARKER.” Transfusion 35, no. 10 (October 1, 1995): S182–S182.Link to Item
-
WASHINGTON, M. K., M. J. TELEN, and M. R. GOTTFRIED. “EXPRESSION OF THE CELL-ADHESION MOLECULE CD44 IN PRIMARY TUMORS OF THE LIVER.” Hepatology 22, no. 4 (October 1, 1995): 1606–1606.Link to Item
-
Mudad, R., N. Rao, P. Angelisova, V. Horejsi, and M. J. Telen. “Evidence that CDw108 membrane protein bears the JMH blood group antigen.” Transfusion 35, no. 7 (July 1995): 566–70. https://doi.org/10.1046/j.1537-2995.1995.35795357878.x.Full Text Link to Item
-
Rao, N., M. Udani, J. Nelson, M. E. Reid, and M. J. Telen. “Investigations using a novel monoclonal antibody to the glycosylphosphatidylinositol-anchored protein that carries Gregory, Holley, and Dombrock blood group antigens.” Transfusion 35, no. 6 (June 1995): 459–64. https://doi.org/10.1046/j.1537-2995.1995.35695288762.x.Full Text Link to Item
-
Telen, M. J., N. Rao, and D. M. Lublin. “Location of WESb on decay-accelerating factor.” Transfusion 35, no. 3 (March 1995): 278. https://doi.org/10.1046/j.1537-2995.1995.35395184292.x.Full Text Link to Item
-
Telen, M. J. “Erythrocyte blood group antigens: not so simple after all.” Blood 85, no. 2 (January 15, 1995): 299–306.Link to Item
-
Telen, M. J. “Blood group antigens on complement receptor/regulatory proteins.” Transfus Med Rev 9, no. 1 (January 1995): 20–28. https://doi.org/10.1016/s0887-7963(05)80028-8.Full Text Link to Item
-
Telen, M. J. “Glycosyl phosphatidylinositol-linked blood group antigens and paroxysmal nocturnal hemoglobinuria.” Transfus Clin Biol 2, no. 4 (1995): 277–90. https://doi.org/10.1016/s1246-7820(05)80094-1.Full Text Link to Item
-
Telen, M. J. “Lutheran antigens, CD44-related antigens, and Lutheran regulatory genes.” Transfus Clin Biol 2, no. 4 (1995): 291–301. https://doi.org/10.1016/s1246-7820(05)80095-3.Full Text Link to Item
-
Udani, M. N., N. Anderson, N. Rao, and M. J. Telen. “Identification of the Tcb allele of the Cromer blood group gene by PCR and RFLP analysis.” Immunohematology 11, no. 1 (1995): 1–4.Link to Item
-
MUDAD, R., N. RAO, P. ANGELISOVA, V. HOREJSI, and M. J. TELEN. “EVIDENCE THAT CDW108 MEMBRANE-PROTEIN BEARS THE JMH BLOOD-GROUP ANTIGEN.” Blood 84, no. 10 (November 15, 1994): A237–A237.Link to Item
-
Telen, M. J., N. Rao, M. Udani, E. S. Thompson, R. M. Kaufman, and D. M. Lublin. “Molecular mapping of the Cromer blood group Cra and Tca epitopes of decay accelerating factor: toward the use of recombinant antigens in immunohematology.” Blood 84, no. 9 (November 1, 1994): 3205–11.Link to Item
-
RAO, N., M. UDANI, and M. J. TELEN. “DEMONSTRATION BY MONOCLONAL-ANTIBODY IMMOBILIZATION OF ERYTHROCYTE ANTIGENS AND DOT-BLOT THAT BOTH THE IN AND ANJW BLOOD-GROUP ANTIGENS RESIDE ON CD44.” Transfusion 34, no. 10 (October 1, 1994): S25–S25.Link to Item
-
RAO, N., and M. J. TELEN. “FURTHER EVIDENCE USING MONOCLONAL-ANTIBODY IMMOBILIZATION OF ERYTHROCYTE ANTIGENS THAT THE HY, GY(A), AND DO(B) ANTIGENS RESIDE ON THE SAME PROTEIN.” Transfusion 34, no. 10 (October 1, 1994): S25–S25.Link to Item
-
WASHINGTON, M. K., M. UDANI, N. RAO, E. LLOYD, and M. J. TELEN. “MOLECULAR-GENETIC BASIS OF THE IN-A/B POLYMORPHISM.” Transfusion 34, no. 10 (October 1, 1994): S62–S62.Link to Item
-
WHITTAKER, D. S., and M. J. TELEN. “EXPRESSION OF PHOSPHATIDYLINOSITOL-LINKED PROTEINS AND BLOOD-GROUP ANTIGENS IN DIABETIC-PATIENTS.” Transfusion 34, no. 10 (October 1, 1994): S63–S63.Link to Item
-
Washington, K., M. R. Gottfried, and M. J. Telen. “Expression of the cell adhesion molecule CD44 in gastric adenocarcinomas.” Hum Pathol 25, no. 10 (October 1994): 1043–49. https://doi.org/10.1016/0046-8177(94)90063-9.Full Text Link to Item
-
Lublin, D. M., G. Mallinson, J. Poole, M. E. Reid, E. S. Thompson, B. R. Ferdman, M. J. Telen, D. J. Anstee, and M. J. Tanner. “Molecular basis of reduced or absent expression of decay-accelerating factor in Cromer blood group phenotypes.” Blood 84, no. 4 (August 15, 1994): 1276–82.Link to Item
-
Washington, K., M. R. Gottfried, and M. J. Telen. “Tissue culture of epithelium derived from Barrett's oesophagus.” Gut 35, no. 7 (July 1994): 879–83. https://doi.org/10.1136/gut.35.7.879.Full Text Link to Item
-
COBOURN, S. D., J. K. LICKER, J. KURTZBERG, and M. J. TELEN. “EXPRESSION OF CD44 ISOFORMS DURING ERYTHROID-DIFFERENTIATION.” Clinical Research 42, no. 2 (April 1, 1994): A131–A131.Link to Item
-
Telen, M. J., and N. Rao. “Recent advances in immunohematology.” Curr Opin Hematol 1, no. 2 (March 1994): 143–50.Link to Item
-
Lindberg, F. P., D. M. Lublin, M. J. Telen, R. A. Veile, Y. E. Miller, H. Donis-Keller, and E. J. Brown. “Rh-related antigen CD47 is the signal-transducer integrin-associated protein.” J Biol Chem 269, no. 3 (January 21, 1994): 1567–70.Link to Item
-
Liao, H. X., M. C. Levesque, K. Patton, B. Bergamo, D. Jones, M. A. Moody, M. J. Telen, and B. F. Haynes. “Regulation of human CD44H and CD44E isoform binding to hyaluronan by phorbol myristate acetate and anti-CD44 monoclonal and polyclonal antibodies.” J Immunol 151, no. 11 (December 1, 1993): 6490–99.Link to Item
-
RAO, N., M. E. REID, and M. J. TELEN. “INVESTIGATION OF THE HOLLEY GREGORY DOMBROCK BLOOD-GROUP ANTIGEN PROTEIN USING A NOVEL MONOCLONAL-ANTIBODY.” Blood 82, no. 10 (November 15, 1993): A267–A267.Link to Item
-
RAO, N., J. BUMGARNER, and M. J. TELEN. “CHARACTERIZATION OF A MONOCLONAL-ANTIBODY THAT DETECTS AN ANTIGEN-RELATED TO GREGORY.” Transfusion 33, no. 9 (September 1, 1993): S48–S48.Link to Item
-
TELEN, M. J., N. RAO, M. UDANI, H. X. LIAO, and B. F. HAYNES. “RELATIONSHIP OF THE ANWJ BLOOD-GROUP ANTIGEN TO EXPRESSION OF CD-44.” Transfusion 33, no. 9 (September 1, 1993): S48–S48.Link to Item
-
TELEN, M. J., N. RAO, M. UDANI, H. X. LIAO, and B. F. HAYNES. “THE ANWJ BLOOD-GROUP ANTIGEN HAEMOPHILUS-INFLUENZAE RECEPTOR RESIDES ON A HIGH-MOLECULAR-WEIGHT PROTEIN EXPRESSED BY CD44 TRANSFECTANTS.” Clinical Research 41, no. 2 (April 1, 1993): A161–A161.Link to Item
-
LUBLIN, D. M., and M. J. TELEN. “MORE ABOUT USE OF THE TERM DR(B) - REPLY.” Transfusion 33, no. 2 (February 1, 1993): 182–182.Link to Item
-
Lewis, M., and P. J. McAlpine. “More about use of the term Drb.” Transfusion 33, no. 2 (February 1993): 182. https://doi.org/10.1046/j.1537-2995.1993.33293158056.x.Full Text Link to Item
-
Rao, N., C. F. Whitsett, S. M. Oxendine, and M. J. Telen. “Human erythrocyte acetylcholinesterase bears the Yta blood group antigen and is reduced or absent in the Yt(a-b-) phenotype.” Blood 81, no. 3 (February 1, 1993): 815–19.Link to Item
-
Poss, M. T., J. L. Swanson, M. J. Telen, L. C. Lasky, and D. A. Vallera. “Monoclonal antibody recognizing a unique Rh-related specificity.” Vox Sang 64, no. 4 (1993): 231–39. https://doi.org/10.1111/j.1423-0410.1993.tb03061.x.Full Text Link to Item
-
WASHINGTON, M. K., M. R. GOTTFRIED, and M. J. TELEN. “EXPRESSION OF THE CELL-ADHESION MOLECULE CD44 IN GASTRIC ADENOCARCINOMAS.” Laboratory Investigation 68, no. 1 (January 1, 1993): A52–A52.Link to Item
-
WASHINGTON, M. K., M. R. GOTTFRIED, and M. J. TELEN. “PRIMARY CULTURES OF EPITHELIUM DERIVED FROM BARRETTS-ESOPHAGUS.” Laboratory Investigation 68, no. 1 (January 1, 1993): A53–A53.Link to Item
-
ISSITT, P. D., M. R. COMBS, T. D. SAMMONS, J. C. SIZEMORE, and M. J. TELEN. “DIFFICULTIES IN SEPARATING 2 CELL-POPULATIONS IN A NEW CHIMERA.” Transfusion 32, no. 8 (October 1, 1992): S55–S55.Link to Item
-
ISSITT, P. D., R. B. ROY, M. R. COMBS, J. BUMGARNER, N. RAO, and M. J. TELEN. “SEROLOGICAL AND BIOCHEMICAL-CHARACTERIZATION OF A JMH VARIANT PHENOTYPE.” Transfusion 32, no. 8 (October 1, 1992): S55–S55.Link to Item
-
LUBLIN, D. M., G. MALLINSON, M. E. REID, J. POOLE, E. S. THOMPSON, B. R. FERDMAN, M. J. TELEN, D. J. ANSTEE, and M. J. A. TANNER. “MOLECULAR-BASIS OF REDUCED OR ABSENT EXPRESSION OF DECAY ACCELERATING FACTOR IN DR(A-) AND INAB PHENOTYPES OF CROMER BLOOD-GROUP.” Transfusion 32, no. 8 (October 1, 1992): S47–S47.Link to Item
-
OXENDINE, S. M., M. J. TELEN, N. RAO, V. HARE, C. FRIESEN, J. STORRY, J. A. PIERCE, and C. F. WHITSETT. “THE CARTWRIGHT NEGATIVE PHENOTYPE - AN ACQUIRED PHENOMENON ASSOCIATED WITH ANTI-YTAB-LIKE ANTIBODY.” Transfusion 32, no. 8 (October 1, 1992): S18–S18.Link to Item
-
TELEN, M. J., M. J. WOODLAND, and N. RAO. “BIOCHEMICAL INVESTIGATION OF THE 2 PROTEIN SPECIES BEARING LUTHERAN ANTIGENS.” Transfusion 32, no. 8 (October 1, 1992): S48–S48.Link to Item
-
TELEN, M. J., N. RAO, E. S. THOMPSON, and D. M. LUBLIN. “MAPPING AND CHARACTERIZATION OF THE CRA EPITOPE OF DECAY ACCELERATING FACTOR.” Transfusion 32, no. 8 (October 1, 1992): S47–S47.Link to Item
-
Daniels, G. “What is a blood group antigen?” Transfusion 32, no. 5 (June 1992): 492–93. https://doi.org/10.1046/j.1537-2995.1992.32592327725.x.Full Text Link to Item
-
LUBLIN, D. M., and M. J. TELEN. “WHAT IS A BLOOD-GROUP ANTIGEN - REPLY.” Transfusion 32, no. 5 (June 1, 1992): 493–493.Link to Item
-
Chapman, J., M. F. Murphy, and A. H. Waters. “Auto-anti-M causing immune hemolysis in vitro.” Transfusion 32, no. 4 (May 1992): 391. https://doi.org/10.1046/j.1537-2995.1992.32492263457.x.Full Text Link to Item
-
TELEN, M. J., and C. F. WHITSETT. “ERYTHROCYTE ACETYLCHOLINESTERASE BEARS THE CARTWRIGHT BLOOD-GROUP ANTIGENS.” Clinical Research 40, no. 2 (April 1, 1992): A170–A170.Link to Item
-
Bobolis, K. A., J. J. Moulds, and M. J. Telen. “Isolation of the JMH antigen on a novel phosphatidylinositol-linked human membrane protein.” Blood 79, no. 6 (March 15, 1992): 1574–81.Link to Item
-
COMBS, M. R., P. D. ISSI‐IT, and M. J. TELEN. “Reply.” Transfusion 32, no. 4 (January 1, 1992): 391–391. https://doi.org/10.1111/j.1537-2995.1992.tb02678.x.Full Text
-
Telen, M. J., and W. F. Rosse. “Phosphatidylinositol-glycan linked proteins of the erythrocyte membrane.” Baillieres Clin Haematol 4, no. 4 (December 1991): 849–68. https://doi.org/10.1016/s0950-3536(06)80033-8.Full Text Link to Item
-
Bepler, G., S. E. Hoffman, B. P. Thompson, M. J. Telen, and W. F. Rosse. “Captopril-enhanced binding of PlA1 (HPA-1a) antibodies in posttransfusion purpura.” Transfusion 31, no. 8 (October 1991): 752–55. https://doi.org/10.1046/j.1537-2995.1991.31892023503.x.Full Text Link to Item
-
Combs, M. R., M. M. O’Rourke, P. D. Issitt, and M. J. Telen. “An auto-anti-M causing hemolysis in vitro.” Transfusion 31, no. 8 (October 1991): 756–58. https://doi.org/10.1046/j.1537-2995.1991.31892023504.x.Full Text Link to Item
-
Telen, M. J., C. Le Van Kim, A. Chung, J. P. Cartron, and Y. Colin. “Molecular basis for elliptocytosis associated with glycophorin C and D deficiency in the Leach phenotype.” Blood 78, no. 6 (September 15, 1991): 1603–6.Link to Item
-
Lublin, D. M., E. S. Thompson, A. M. Green, C. Levene, and M. J. Telen. “Dr(a-) polymorphism of decay accelerating factor. Biochemical, functional, and molecular characterization and production of allele-specific transfectants.” J Clin Invest 87, no. 6 (June 1991): 1945–52. https://doi.org/10.1172/JCI115220.Full Text Link to Item
-
Rao, N., D. J. Ferguson, S. F. Lee, and M. J. Telen. “Identification of human erythrocyte blood group antigens on the C3b/C4b receptor.” J Immunol 146, no. 10 (May 15, 1991): 3502–7.Link to Item
-
Telen, M. J., C. Le Van Kim, M. L. Guizzo, J. P. Cartron, and Y. Colin. “Erythrocyte Webb-type glycophorin C variant lacks N-glycosylation due to an asparagine to serine substitution.” Am J Hematol 37, no. 1 (May 1991): 51–52. https://doi.org/10.1002/ajh.2830370112.Full Text Link to Item
-
Telen, M. J. “Phosphatidylinositol-linked red blood cell membrane proteins and blood group antigens.” Immunohematology 7, no. 3 (1991): 65–72.Link to Item
-
Telen, M. J., and J. A. Chasis. “Relationship of the human erythrocyte Wrb antigen to an interaction between glycophorin A and band 3.” Blood 76, no. 4 (August 15, 1990): 842–48.Link to Item
-
RAO, N. C., D. J. FERGUSON, S. F. LEE, and M. J. TELEN. “THE RELATIONSHIP BETWEEN THE COMPLEMENT RECEPTOR TYPE-1 AND THE KNOPS MCCOY ANTIGEN SYSTEM.” Clinical Research 38, no. 2 (April 1, 1990): A303–A303.Link to Item
-
Telen, M. J., W. F. Rosse, C. J. Parker, M. K. Moulds, and J. J. Moulds. “Evidence that several high-frequency human blood group antigens reside on phosphatidylinositol-linked erythrocyte membrane proteins.” Blood 75, no. 7 (April 1, 1990): 1404–7.Link to Item
-
Combs, M. R., M. J. Telen, S. E. Hall, and W. F. Rosse. “A case report: IgG autoanti-N as a cause of severe autoimmune hemolytic anemia.” Immunohematology 6, no. 4 (1990): 83–86.Link to Item
-
Telen, M. J., K. B. Roberts, and J. A. Bartlett. “HIV-associated autoimmune hemolytic anemia: report of a case and review of the literature.” J Acquir Immune Defic Syndr (1988) 3, no. 10 (1990): 933–37.Link to Item
-
Telen, M. J., and D. J. Ferguson. “Relationship of Inb antigen to other antigens on In(Lu)-related p80.” Vox Sang 58, no. 2 (1990): 118–21. https://doi.org/10.1111/j.1423-0410.1990.tb02073.x.Full Text Link to Item
-
Haynes, B. F., M. J. Telen, L. P. Hale, and S. M. Denning. “CD44--a molecule involved in leukocyte adherence and T-cell activation.” Immunol Today 10, no. 12 (December 1989): 423–28. https://doi.org/10.1016/0167-5699(89)90040-6.Full Text Link to Item
-
Telen, M. J., and A. M. Green. “The Inab phenotype: characterization of the membrane protein and complement regulatory defect.” Blood 74, no. 1 (July 1989): 437–41.Link to Item
-
Picker, L. J., J. De los Toyos, M. J. Telen, B. F. Haynes, and E. C. Butcher. “Monoclonal antibodies against the CD44 [In(Lu)-related p80], and Pgp-1 antigens in man recognize the Hermes class of lymphocyte homing receptors.” J Immunol 142, no. 6 (March 15, 1989): 2046–51.Link to Item
-
Lucas, M. G., A. M. Green, and M. J. Telen. “Characterization of the serum In(Lu)-related antigen: identification of a serum protein related to erythrocyte p80.” Blood 73, no. 2 (February 1989): 596–600.Link to Item
-
Telen, M. J., and A. M. Green. “Human red cell antigens. V. Expression of In(Lu)-related p80 antigens by recessive-type Lu(a-b-) red cells.” Transfusion 28, no. 5 (September 1988): 430–34. https://doi.org/10.1046/j.1537-2995.1988.28588337330.x.Full Text Link to Item
-
Telen, M. J., S. E. Hall, A. M. Green, J. J. Moulds, and W. F. Rosse. “Identification of human erythrocyte blood group antigens on decay-accelerating factor (DAF) and an erythrocyte phenotype negative for DAF.” J Exp Med 167, no. 6 (June 1, 1988): 1993–98. https://doi.org/10.1084/jem.167.6.1993.Full Text Link to Item
-
TELEN, M. J., S. E. HALL, A. GREEN, and W. F. ROSSE. “IDENTIFICATION OF HUMAN-BLOOD GROUP ANTIGENS ON DECAY ACCELERATING FACTOR AND DEMONSTRATION OF A NULL PHENOTYPE.” Clinical Research 36, no. 3 (April 1, 1988): A421–A421.Link to Item
-
Telen, M. J., A. Green, and T. Young. “Serological and biochemical characterization of monoclonal antibodies against red cell markers related to expression of Lutheran blood group antigens.” Rev Fr Transfus Immunohematol 31, no. 2 (April 1988): 421–28. https://doi.org/10.1016/s0338-4535(88)80133-8.Full Text Link to Item
-
Telen, M. J., A. Green, and T. Young. “Biochemical characterization of antibodies submitted as reactive with glycophorin species.” Rev Fr Transfus Immunohematol 31, no. 2 (April 1988): 309–15. https://doi.org/10.1016/s0338-4535(88)80117-x.Full Text Link to Item
-
TELEN, M. J. “EVIDENCE THAT WRB ANTIGEN INVOLVES INTERACTION BETWEEN BAND 3 AND GLYCOPHORIN-A.” Transfusion 27, no. 6 (November 1, 1987): 534–534.Link to Item
-
Telen, M. J., I. Rogers, and M. Letarte. “Further characterization of erythrocyte p80 and the membrane protein defect of In(Lu) Lu(a-b-) erythrocytes.” Blood 70, no. 5 (November 1987): 1475–81.Link to Item
-
Telen, M. J., and T. A. Bolk. “Human red cell antigens. IV. The abnormal sialoglycoprotein of Gerbich-negative red cells.” Transfusion 27, no. 4 (July 1987): 309–14. https://doi.org/10.1046/j.1537-2995.1987.27487264736.x.Full Text Link to Item
-
Srikanta, S., M. Telen, J. T. Posillico, R. Dolinar, K. Krisch, B. F. Haynes, and G. S. Eisenbarth. “Monoclonal antibodies to a human islet cell surface glycoprotein: 4F2 and LC7-2.” Endocrinology 120, no. 6 (June 1987): 2240–44. https://doi.org/10.1210/endo-120-6-2240.Full Text Link to Item
-
Telen, M. J., R. M. Scearce, and B. F. Haynes. “Human erythrocyte antigens. III. Characterization of a panel of murine monoclonal antibodies that react with human erythrocyte and erythroid precursor membranes.” Vox Sang 52, no. 3 (1987): 236–43. https://doi.org/10.1111/j.1423-0410.1987.tb03035.x.Full Text Link to Item
-
Telen, Marilyn J., Richard M. Scearce, and Barton F. Haynes. “Human Erythrocyte Antigens.” Vox Sanguinis 52, no. 3 (1987): 236–43. https://doi.org/10.1159/000461656.Full Text
-
TELEN, M. J., and M. LETARTE. “THE MEMBRANE GLYCOPROTEIN DEFECT OF IN(LU) LU(A-B-) ERYTHROCYTES (E).” Transfusion 26, no. 6 (November 1, 1986): 574–574.Link to Item
-
Telen, M. J., H. Shehata, and B. F. Haynes. “Human medullary thymocyte p80 antigen and In(Lu)-related p80 antigen reside on the same protein.” Hum Immunol 17, no. 3 (November 1986): 311–24. https://doi.org/10.1016/0198-8859(86)90283-1.Full Text Link to Item
-
Chow, F. L., S. E. Hall, W. F. Rosse, and M. J. Telen. “Separation of the acetylcholinesterase-deficient red cells in paroxysmal nocturnal hemoglobinuria.” Blood 67, no. 4 (April 1986): 893–97.Link to Item
-
Chow, F. L., M. J. Telen, and W. F. Rosse. “The acetylcholinesterase defect in paroxysmal nocturnal hemoglobinuria: evidence that the enzyme is absent from the cell membrane.” Blood 66, no. 4 (October 1985): 940–45.Link to Item
-
Telen, M. J. “An antibody to human thymic Hassall's body epithelium recognizes a subset of blood group A antigens.” J Immunogenet 12, no. 1 (February 1985): 3–15. https://doi.org/10.1111/j.1744-313x.1985.tb00825.x.Full Text Link to Item
-
TELEN, M. J., and T. BOLK. “THE MEMBRANE DEFECT OF GERBICH-NEGATIVE (GE-) ERYTHROCYTES (E).” Transfusion 25, no. 5 (January 1, 1985): 464–464.Link to Item
-
Parker, C. J., C. M. Soldato, and M. J. Telen. “Increased efficiency of binding of nascent C3b to the erythrocytes of chronic cold agglutinin disease.” J Clin Invest 74, no. 3 (September 1984): 1050–62. https://doi.org/10.1172/JCI111472.Full Text Link to Item
-
Telen, M. J., T. J. Palker, and B. F. Haynes. “Human erythrocyte antigens: II. The In(Lu) gene regulates expression of an antigen on an 80-kilodalton protein of human erythrocytes.” Blood 64, no. 3 (September 1984): 599–606.Link to Item
-
Haynes, B. F., M. J. Telen, M. J. PalkerTJ, E. Harden, and R. M. Scearce. “Monoclonal antibody defines human cell surface protein p80 on intrathymic T cells.” J Immunol 132, no. 5 (May 1984): 2678.Link to Item
-
Haynes, B. F., E. A. Harden, M. J. Telen, M. E. Hemler, J. L. Strominger, T. J. Palker, R. M. Scearce, and G. S. Eisenbarth. “Differentiation of human T lymphocytes. I. Acquisition of a novel human cell surface protein (p80) during normal intrathymic T cell maturation.” J Immunol 131, no. 3 (September 1983): 1195–1200.Link to Item
-
Telen, M. J., G. S. Eisenbarth, and B. F. Haynes. “Human erythrocyte antigens. Regulation of expression of a novel erythrocyte surface antigen by the inhibitor Lutheran In(Lu) gene.” J Clin Invest 71, no. 6 (June 1983): 1878–86. https://doi.org/10.1172/jci110943.Full Text Link to Item
-
EISENBARTH, G. S., M. J. TELEN, C. PETERSON, T. REIMAN, and B. F. HAYNES. “CHARACTERIZATION OF A NOVEL CELL-SURFACE GLYCOPROTEIN COEXPRESSED ON CELLS BEARING THE INSULIN-RECEPTOR AND SELECTIVELY EXPRESSED ON PANCREATIC-ISLET CELLS.” Clinical Research 30, no. 2 (January 1, 1982): A391–A391.Link to Item
-
TELEN, M. J., G. S. EISENBARTH, and B. F. HAYNES. “CHARACTERIZATION AND DISTRIBUTION OF A LUTHERAN ERYTHROCYTE ANTIGEN AS DEFINED BY A MONOCLONAL-ANTIBODY.” Clinical Research 30, no. 2 (January 1, 1982): A331–A331.Link to Item
-
Issitt, Peter D., and Marilyn J. Telen. “Introduction of the term “partial D”.” Transfusion 36, no. 8 (n.d.): 761–62. https://doi.org/10.1111/j.1537-2995.1996.tb05625.x.Full Text
-
Liggett, L Alexander, Liam D. Cato, Joshua S. Weinstock, Yingze Zhang, Seyed Mehdi Nouraie, Mark T. Gladwin, Melanie E. Garrett, et al. “Clonal hematopoiesis in sickle cell disease,” n.d. https://doi.org/10.1101/2021.06.12.21258772.Full Text
-
Telen, Marilyn, and Joseph Bundy. “RNA-sequencing of isolated cell populations expressing human APOL1 G2 risk variant reveals molecular correlates of sickle cell nephropathy in zebrafish podocytes.,” n.d.
-
-
Book Sections
-
Stamler, J. S., and M. J. Telen. “Functions of blood group antigens.” In Molecular Hematology, 285–96, 2019. https://doi.org/10.1002/9781119252863.ch21.Full Text
-
Kaufman, Russel, and M. J. Telen. “The mature erythrocyte function.” In Wintrobe’s Clinical Hematology ... Williams and Wilkins, 2004.
-
Kaufman, Russel, and M. J. Telen. “The mature erythrocyte function.” In Wintrobe’s Clinical Hematology. Williams & Wilkins, 1999.
-
Rao, Neeraja, and Marilyn J. Telen. “Lutheran Antigens, Lutheran Regulatory Genes, and Lutheran Regulatory Gene Targets.” In Molecular Basis of Human Blood Group Antigens, 281–97. Springer US, 1995. https://doi.org/10.1007/978-1-4757-9537-0_10.Full Text
-
Telen, Marilyn J. “Expression of Human Erythrocyte Membrane Protein Antigens during Erythroid Differentiation.” In Blood Cell Biochemistry, 27–43. Springer US, 1990. https://doi.org/10.1007/978-1-4757-9528-8_2.Full Text
-
Pawloski, John R., and Marilyn J. Telen. “Functions of Blood Group Antigens.” In Molecular Hematology, 241–50. Blackwell Publishing Ltd, n.d. https://doi.org/10.1002/9780470987063.ch20.Full Text
-
-
Conference Papers
-
Kalfa, Theodosia A., Marilyn J. Telen, Santosh L. Saraf, R Clark Brown, Katie Giger Seu, Sandra K. Larkin, Eric Soupene, et al. “Etavopivat, an investigational, once-daily, selective pyruvate kinase-R activator, improves sickle red blood cell health and survival in patients with sickle cell disease: an analysis of exploratory studies in a phase 1 trial.” In British Journal of Haematology, 197:12–13, 2022.Link to Item
-
Brown, R Clark, Kimberly Cruz, Theodosia A. Kalfa, Frans A. Kuypers, Santosh L. Saraf, Jeremie H. Estepp, Luke R. Smart, et al. “FT-4202, an allosteric activator of pyruvate kinase-R, demonstrates proof of mechanism and proof of concept after multiple daily doses in a phase 1 study of patients with sickle cell disease.” In British Journal of Haematology, 193:23–24, 2021.Link to Item
-
Wen, Fayuan, Angela Rock, Juan Salomon-Andonie, Gulriz Kurban, Xiaomei Niu, Songping Wang, Xu Zhang, et al. “Genome Wide Association Analysis of Iron Overload in the Trans-Omics for Precision Medicine (TOPMed) Sickle Cell Disease Cohorts.” In Blood, 136:52–52. American Society of Hematology, 2020. https://doi.org/10.1182/blood-2020-142809.Full Text
-
Kachroo, Priyadarshini, Julian Hecker, Bo L. Chawes, Tarunveer S. Ahluwalia, Michael H. Cho, Dandi Qiao, Rachel S. Kelly, et al. “Whole Genome Sequencing Identifies CRISPLD2 as a Lung Function Gene in Children With Asthma.” In Chest, 156:1068–79, 2019. https://doi.org/10.1016/j.chest.2019.08.2202.Full Text Link to Item
-
Kalfa, Theodosia A., Frans A. Kuypers, Marilyn J. Telen, Punam Malik, Diamantis G. Konstantinidis, Jeremy H. Estepp, Hyon J. Kim, et al. “Phase 1 Single (SAD) and Multiple Ascending Dose (MAD) Studies of the Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of FT-4202, an Allosteric Activator of Pyruvate Kinase-R, in Healthy and Sickle Cell Disease Subjects.” In Blood, 134:616–616. American Society of Hematology, 2019. https://doi.org/10.1182/blood-2019-121889.Full Text
-
Xu, Julia Z., Meghan Foe, Wilaslak Tanongsaksakul, Thidarat Suksangpleng, Supachai Ekwattanakit, Suchada Riolueang, Marilyn J. Telen, Bonnie N. Kaiser, and Vip Viprakasit. “Identification of Optimal Thalassemia Screening Strategies for Migrant Populations in Thailand: A Mixed-Methods Approach.” In Blood, 134:2112–2112. American Society of Hematology, 2019. https://doi.org/10.1182/blood-2019-131805.Full Text
-
Bundy, Joseph L., Blair R. Anderson, Ludmila Francescatto, Melanie E. Garrett, Karen L. Soldano, Marilyn J. Telen, Erica E. Davis, and Allison E. Ashley-Koch. “RNA sequencing of isolated cell populations expressing human APOL1 G2 risk variant reveals molecular correlates of sickle cell nephropathy in zebrafish podocytes.” In Plos One, 14:e0217042, 2019. https://doi.org/10.1371/journal.pone.0217042.Full Text Link to Item
-
Xu, Julia Z., Wilaslak Tanongsaksakul, Thidarat Suksangpleng, Supachai Ekwattanakit, Suchada Riolueang, Bonnie N. Kaiser, Nathan M. Thielman, Marilyn J. Telen, and Vip Viprakasit. “Knowledge, Cultural, and Structural Barriers to Thalassemia Screening in Migrant Populations in Thailand.” In Blood, 132:2228–2228. American Society of Hematology, 2018. https://doi.org/10.1182/blood-2018-99-114117.Full Text
-
Anderson, Blair R., Melanie E. Garrett, Karen L. Soldano, Eugene P. Orringer, James R. Eckman, Ludmila Francescatto, Erica E. Davis, et al. “GWAS Meta-Analysis of Glomerular Filtration Rate in Three Cohorts of Sickle Cell Disease Patients and In Vivo Functional Analysis Reveals Potential Nephropathy Candidate Genes.” In Blood, 128:269–269. American Society of Hematology, 2016. https://doi.org/10.1182/blood.v128.22.269.269.Full Text
-
Chang, Jennifer Minjia, Martha Delahunty, Milena Batchvarova, Karen L. Soldano, J Michael Cook, and Marilyn J. Telen. “Effect of FXIII Polymorphism on Formation of Heterocellular Aggregates in SCD.” In Blood, 128:3648–3648. American Society of Hematology, 2016. https://doi.org/10.1182/blood.v128.22.3648.3648.Full Text
-
Jacob, Seethal A., Enrico M. Novelli, Jeffrey S. Isenberg, Melanie E. Garrett, Yanxia Chu, Karen L. Soldano, Kenneth I. Ataga, et al. “Thrombospondin-1 Polymorphisms Are Associated with Chronic Kidney Disease in Sickle Cell Anemia.” In Blood, 128:2491–2491. American Society of Hematology, 2016. https://doi.org/10.1182/blood.v128.22.2491.2491.Full Text
-
Narine, Kalindi Yajnik, Jennifer Minjia Chang, Jude Jonassaint, Marilyn J. Telen, and Nirmish Shah. “Use of Mobile Technology to Monitor Pain and Reduce Outpatient, Emergency Department (ED), and Hospital Visits for Sickle Cell Pain Crisis.” In Blood, 128:2390–2390. American Society of Hematology, 2016. https://doi.org/10.1182/blood.v128.22.2390.2390.Full Text
-
Xu, Julia Z., Melanie E. Garrett, Karen L. Soldano, Sean T. Chen, Allison E. Ashley-Koch, and Marilyn J. Telen. “Factors Related to the Progression of Sickle Cell Disease Nephropathy.” In Blood, 128:9–9. American Society of Hematology, 2016. https://doi.org/10.1182/blood.v128.22.9.9.Full Text
-
Garrett, Melanie E., Karen L. Soldano, Blair R. Anderson, Marilyn J. Telen, and Allison E. Ashley-Koch. “Genome-Wide Evaluation of Epistasis with APOL1 Risk Variants in Sickle Cell Disease Nephropathy.” In Blood, Vol. 126. AMER SOC HEMATOLOGY, 2015.Link to Item
-
Anderson, Blair R., Erica E. Davis, Marilyn J. Telen, and Allison E. Ashley-Koch. “Evidence for a Dominant Negative Effect Conferred By the APOL1 G2 Sickle Cell Nephropathy Risk Allele in an in Vivo Model.” In Blood, Vol. 124. AMER SOC HEMATOLOGY, 2014.Link to Item
-
Doss, Jennifer, Jude Jonassaint, Nirmish Shah, Marilyn J. Telen, and Jen-Tsan A. Chi. “Effects of Sulforaphane Obtained from Broccoli Sprout Homogenate in Patients with Sickle Cell Disease (SCD).” In Blood, Vol. 124. AMER SOC HEMATOLOGY, 2014.Link to Item
-
Elmariah, Hany, Melanie E. Garrett, Karen L. Soldano, Kenneth I. Ataga, James R. Eckman, Marilyn J. Telen, and Allison E. Ashley-Koch. “Genes Associated with Survival in Adult Sickle Cell Disease.” In Blood, Vol. 124. AMER SOC HEMATOLOGY, 2014.Link to Item
-
Garrett, Melanie E., Karen L. Soldano, Blair R. Anderson, Eugene P. Orringer, James R. Eckman, Marilyn J. Telen, and Allison E. Ashley-Koch. “Genome-Wide Association Study of Glomerular Filtration Rate in a Cohort of Sickle Cell Disease Patients.” In Blood, Vol. 124. AMER SOC HEMATOLOGY, 2014.Link to Item
-
Milton, Jacqueline N., Allison E. Ashley-Koch, Melanie E. Garrett, Karen L. Soldano, Eugene P. Orringer, Paola Sebastiani, Daniel A. Dworkis, Karen Quillen, Martin H. Steinberg, and Marilyn J. Telen. “Genes Associated with Alloimmunization to Blood Group Antigens in Sickle Cell Disease.” In Blood, Vol. 124. AMER SOC HEMATOLOGY, 2014.Link to Item
-
Wun, Ted, Marilyn J. Telen, Lakshmanan Krishnamurti, Timothy L. McCavit, Laura M. DeCastro, Henry Flanner, Frans A. Kuypers, et al. “Pan-Selectin Antagonist Rivipansel (GMI-1070) Reduces Soluble E-Selectin Levels While Improving Clinical Outcomes in SCD Vaso-Occlusive Crisis.” In Blood, 124:2704–2704. American Society of Hematology, 2014. https://doi.org/10.1182/blood.v124.21.2704.2704.Full Text
-
Anderson, Blair R., Erica E. Davis, Marilyn J. Telen, and Allison E. Ashley-Koch. “In Vivo Modeling Of Genetic Mechanisms Associated With Sickle Cell Disease Nephropathy.” In Blood, 122:2224–2224. American Society of Hematology, 2013. https://doi.org/10.1182/blood.v122.21.2224.2224.Full Text
-
Batchvarova, Milena, Siqing Shan, Rahima Zennadi, Maria Lindgren, Anna Leitgeb, Pirkko Sulila Tamsen, and Marilyn J. Telen. “Sevuparin Reduces Adhesion Of Both Sickle Red Cells and Leukocytes To Endothelial Cells In Vitro and Inhibits Vaso-Occlusion In Vivo.” In Blood, 122:182–182. American Society of Hematology, 2013. https://doi.org/10.1182/blood.v122.21.182.182.Full Text
-
De Castro, Laura M., Ted Wun, Sophie Lanzkron, Wally R. Smith, Kathryn L. Hassell, Abdullah Kutlar, Kim Smith-Whitley, Seungshin Rhee, Marilyn J. Telen, and Helen Thackray. “Effects Of GMI 1070, a Pan-Selectin Inhibitor, On Pain Intensity and Opioid Utilization In Sickle Cell Disease.” In Blood, 122:775–775. American Society of Hematology, 2013. https://doi.org/10.1182/blood.v122.21.775.775.Full Text
-
Telen, Marilyn J., Ted Wun, Timothy L. McCavit, Laura M. De Castro, Lakshmanan Krishnamurti, Sophie Lanzkron, Lewis L. Hsu, et al. “GMI 1070: Reduction In Time To Resolution Of Vaso-Occlusive Crisis and Decreased Opioid Use In a Prospective, Randomized, Multi-Center Double Blind, Adaptive Phase 2 Study In Sickle Cell Disease.” In Blood, 122:776–776. American Society of Hematology, 2013. https://doi.org/10.1182/blood.v122.21.776.776.Full Text
-
Magnani, John L., Frans A. Kuypers, John T. Patton, Sandra K. Larkin, Lori Styles, Laura M. DeCastro, Marilyn J. Telen, Ted Wun, and Helen Thackray. “Pan-Selectin Antagonist GMI-1070 Affects Biomarkers of Adhesion, Activation and the Coagulation Cascade in Sickle Cell Adults At Steady State.” In Blood, 120:87–87. American Society of Hematology, 2012. https://doi.org/10.1182/blood.v120.21.87.87.Full Text
-
Shaked, N. T., L. L. Satterwhite, M. J. Telen, G. A. Truskey, and A. Wax. “Dynamic quantitative microscopy and nanoscopy of red blood cells in sickle cell disease.” In Progress in Biomedical Optics and Imaging Proceedings of Spie, Vol. 8227, 2012. https://doi.org/10.1117/12.907659.Full Text
-
Bae, Harold T., Clinton T. Baldwin, Mark T. Gladwin, Allison E. Ashley-Koch, Melanie Garrett, Karen Soldano, James G. Taylor, et al. “An Elevated Tricuspid Regurgitant Jet Velocity in Sickle Cell Disease Is Associated with Polymorphisms in Genes Impacting Innate Immunity.” In Blood, 118:240–240. AMER SOC HEMATOLOGY, 2011.Link to Item
-
Barber, Latorya A., Karen Soldano, Melanie Garrett, Eugene P. Orringer, James R. Eckman, Marilyn J. Telen, and Allison E. Ashley-Koch. “Inflammatory Polymorphisms Link the Risk of Acute Chest Syndrome with Asthma in Adults with Sickle Cell Disease.” In Blood, 118:493–493. AMER SOC HEMATOLOGY, 2011.Link to Item
-
Boateng, Lydia A., Rahima Zennadi, and Marilyn J. Telen. “Sickle Red Blood Cell Induced Adhesion of Neutrophils to Endothelial Cells and Biologic Correlates of Leukocyte Activation.” In Blood, 118:1055–1055. American Society of Hematology, 2011. https://doi.org/10.1182/blood.v118.21.1055.1055.Full Text
-
Agrawal, Shilpa, Martha Delahunty, and Marilyn J. Telen. “Factors Associated with Heterocellular Aggregate Formation In Sickle Cell Disease.” In Blood, 116:1101–1101. AMER SOC HEMATOLOGY, 2010.Link to Item
-
Ashley-Koch, Allison E., Melanie Garrett, Karen Soldano, Latorya A. Barber, and Marilyn J. Telen. “Hydroxyurea Induces Genome-Wide Epigenetic Changes In Sickle Cell Disease.” In Blood, 116:2670–2670. American Society of Hematology, 2010. https://doi.org/10.1182/blood.v116.21.2670.2670.Full Text
-
Barber, Latorya A., Melanie Garrett, Karen Soldano, Eugene P. Orringer, James R. Eckman, Marilyn J. Telen, and Allison E. Ashley-Koch. “Anti-Inflammatory Markers Are Associated with Glomerular Filtration Rate In Adults with Sickle Cell Disease.” In Blood, 116:693–94. AMER SOC HEMATOLOGY, 2010.Link to Item
-
Dampier, Carlton, Wally R. Smith, Carrie Wager, Margaret Bell, James R. Eckman, Lewis L. Hsu, Donna McClish, et al. “Initial Experience with the IMPROVE Trial-a Phase III Analgesic Trial for Hospitalized Sickle Cell Painful Episodes.” In Blood, 116:1100–1100. AMER SOC HEMATOLOGY, 2010.Link to Item
-
Mutucumarana, Charmaine P., Catherine Chandler, Marilyn J. Telen, and Martha Delahunty. “Relationship of Soluble Adhesion Receptors to Red Cell Apoptosis In SCD.” In Blood, 116:694–694. AMER SOC HEMATOLOGY, 2010.Link to Item
-
Okocha, Emmanuel, Melanie Garrett, Karen Soldano, Laura M. De Castro, Jude Jonassaint, Eugene P. Orringer, James R. Eckman, Marilyn J. telen, and Allison E. Ashley-Koch. “Genetic Variation In MYH9 Is Associated with Sickle Cell Disease Nephropathy.” In Blood, 116:692–692. AMER SOC HEMATOLOGY, 2010.Link to Item
-
Styles, Lori, Ted Wun, Laura M. De Castro, Marilyn J. Telen, William Kramer, Henry Flanner, John L. Magnani, and Helen Thackray. “GMI-1070, a Pan-Selectin Inhibitor: Safety and PK In a Phase 1/2 Study In Adults with Sickle Cell Disease.” In Blood, 116:685–86. AMER SOC HEMATOLOGY, 2010.Link to Item
-
Tutaeva, Victoria, J Will Thompson, Matthew W. Foster, M Arthur Moseley, Stephen P. Holly, Martha Delahunty, Leslie V. Parise, and Marilyn J. Telen. “S-Nitrosylation of Rap1and Relationship to Rap1 Activity and Disease Status In SCD.” In Blood, 116:1098–1098. AMER SOC HEMATOLOGY, 2010.Link to Item
-
Zennadi, Rahima, and Marilyn J. Telen. “Atypical Activation of Plasma Membrane-Bound ERK1/2 Is Associated with Regulation of Sickle Red Cell Adhesion to Endothelium.” In Blood, 116:122–122. AMER SOC HEMATOLOGY, 2010.Link to Item
-
Adam, Soheir S., Charlene Flahiff, Mary R. Abrams, Marilyn J. Telen, and Laura M. De Castro. “The Complex Relationship Between Sickle Cell Disease and Depression.” In Blood, 114:1014–15. AMER SOC HEMATOLOGY, 2009.Link to Item
-
Barber, Latorya A., Allison E. Ashley-Koch, Melanie E. Garrett, Karen L. Soldano, and Marilyn J. Telen. “Polymorphisms in TNFα Are Associated with Cerebrovascular Events in Sickle Cell Disease.” In Blood, 114:1540–1540. American Society of Hematology, 2009. https://doi.org/10.1182/blood.v114.22.1540.1540.Full Text
-
Crawford, Regina D., Miriam Feliu, Christopher L. Edwards, and Marilyn J. Telen. “Use of a Computer Based Neurocognitive Software Program in Asymptomatic Neurologically Intact Adults with Sickle Cell Disease.” In Blood, 114:612–612. AMER SOC HEMATOLOGY, 2009.Link to Item
-
Kamble, Shital, Shelby D. Reed, Chelsea Grussemeyer, and Marilyn J. Telen. “In-Hospital Outcomes Among Sickle Cell Patients with Acute Chest Syndrome: Results From a National Database.” In Blood, 114:557–557. AMER SOC HEMATOLOGY, 2009.Link to Item
-
Klings, Elizabeth S., Daniel A. Dworkis, Amanda Sedgewick, Stephen W. Hartley, Ashley-Koch Allison, Marilyn J. Telen, Gregory J. Kato, et al. “Genetic Polymorphisms in NEDD4L Are Associated with Pulmonary Hypertension of Sickle Cell Anemia.” In Blood, 114:2562–2562. American Society of Hematology, 2009. https://doi.org/10.1182/blood.v114.22.2562.2562.Full Text
-
Shah, Nirmish, Marilyn J. Telen, and Thomas L. Ortel. “Comparison of Thrombin Generation of Sickle Cell Patients in Microparticle Rich and Microparticle Poor Plasma Using Thrombin Generation Assay (TGA).” In Blood, 114:1004–1004. AMER SOC HEMATOLOGY, 2009.Link to Item
-
Silbermins, Damian, Agustin Calatroni, Jude Jonassaint, Marilyn J. Telen, and Laura M. De Castro. “Retrospective Review of the Natural History of Pulmonary Hypertension in Sickle Cell Disease Demonstrates That Progressive Enlargement of the Left Atrium Is a Strong Predictor of Death.” In Blood, 114:613–14. AMER SOC HEMATOLOGY, 2009.Link to Item
-
Timofeev, Nadia, Jacqueline N. Milton, Stephen W. Hartley, Richard Sherva, Paola Sebastiani, Daniel A. Dworkis, Elizabeth S. Klings, et al. “Genome-Wide Studies in Sickle Cell Anemia Show Associations Between SNPs in the Olfactory Receptor Gene Cluster and Fetal Hemoglobin Concentration.” In Blood, 114:339–339. AMER SOC HEMATOLOGY, 2009.Link to Item
-
Wang, Winfred C., Cathie Snyder, Carlo Brugnara, Marilyn J. Telen, Martin H. Steinberg, Lynn W. Wynn, Julie McAfee, et al. “Effects of Hydroxyurea (HU) and Magnesium Pidolate (Mg) in Hemoglobin SC Disease (HbSC): the "CHAMPS" Trial.” In Blood, 114:338–338. AMER SOC HEMATOLOGY, 2009.Link to Item
-
Adam, Soheir S., Jude C. Jonassaint, Charles R. Jonassaint, Laura M. De Castro, and Marilyn J. Telen. “The relationship of opiate analgesia to quality of life in an adult sickle cell population.” In Blood, 110:670A-670A. AMER SOC HEMATOLOGY, 2007.Link to Item
-
El Khatib, Aya, Allison Ashley-Koch, Melanie Kail, Ann Collins, Jude Jonassaint, Soheir S. Adam, Kenneth I. Ataga, et al. “Further investigation of the role of factor XIII in priapism associated with SCD.” In Blood, 110:998A-998A. AMER SOC HEMATOLOGY, 2007.Link to Item
-
Jonassaint, Charles R., Jude C. Jonassaint, Allison Ashley-Koch, Soheir S. Adam, Marilyn J. Telen, and Laura M. De Castro. “The Effects of Chronic Opiates Pain Therapy in Sickle Cell Anemia.” In Blood, 110:3404–3404. American Society of Hematology, 2007. https://doi.org/10.1182/blood.v110.11.3404.3404.Full Text
-
Nishimura, Jun-ichi, Angela D. Burnette, Sabah Oney, Milena Batchvarova, Martha Delahunty, Rahima Zennadi, Bruce A. Sullenger, and Marilyn J. Telen. “Blocking adhesion of sickle erythrocytes to endothelial P-selectin using an RNAaptamer.” In Blood, 110:51A-51A. AMER SOC HEMATOLOGY, 2007.Link to Item
-
Xu, Ke, and Marilyn J. Telen. “Sickle RBCs stimulate human monocyte cytokine expression.” In Blood, 110:668A-669A. AMER SOC HEMATOLOGY, 2007.Link to Item
-
De Castro, Laura M., Felicia C. Lennon-Graham, Allison G. Ashley-Koch, Jude C. Jonassaint, James J. Eckman, Eugene P. Orringer, and Marilyn J. Telen. “Current prevalence of specific clinical outcomes in adult patients with HbSS or Hb S beta(0) thalassemia.” In Blood, 108:353A-353A. AMER SOC HEMATOLOGY, 2006.Link to Item
-
De Castro, Laura M., Jude C. Jonassaint, Jennifer G. Johnson, Milena Batchvarova, and Marilyn J. Telen. “Effect of single dose in vivo propranolol therapy on in vitro adhesion of human SS RBC.” In Blood, 108:363A-363A. AMER SOC HEMATOLOGY, 2006.Link to Item
-
Ko, Myung S., Kate K. Xu, and Marilyn J. Telen. “Mechanism of soluble laminin-mediated enhancement of sickle red cell adhesion to endothelial cells.” In Blood, 108:364A-364A. AMER SOC HEMATOLOGY, 2006.Link to Item
-
Zennadi, Rahima, Chloe Chien, Milena Batchvarova, and Marilyn J. Telen. “Interaction of activated sickle red cell LW with leukocytes induces leukocyte adhesion to endothelium via CD44-E-selectin.” In Blood, 108:361A-361A. AMER SOC HEMATOLOGY, 2006.Link to Item
-
Afenyi-Annan, A. N., F. L. Graham, J. Galloway, J. Price, M. R. Combs, J. M. Vance, A. Ashley-Koch, and M. J. Telen. “Allolimmunization and clinical disease severity in sickle cell disease.” In Transfusion, 46:129A-129A. BLACKWELL PUBLISHING, 2006.Link to Item
-
Afenyi-Annan, A. N., F. L. Graham, J. Galloway, J. Price, M. R. Combs, J. M. Vance, A. Ashley-Koch, and M. J. Telen. “Duffy genotype is associated with sickle cell nephropathy.” In Transfusion, 46:2A-3A. WILEY-BLACKWELL, 2006.Link to Item
-
Ashley-Koch, A. E., L. M. De Castro, F. Lennon-Graham, J. Jonassaint, T. L. Jackson, J. Price, J. Galloway, et al. “Priapism in SCD: Clinical and genetic correlations.” In Blood, 106:887A-887A. AMER SOC HEMATOLOGY, 2005.Link to Item
-
Ashley-Koch, A. E., L. M. De Castro, F. Lennon-Graham, J. Jonassaint, T. L. Jackson, J. Price, J. Galloway, et al. “Clinical and genetic profiles of the aging sickle cell patient.” In Blood, 106:26A-26A. AMER SOC HEMATOLOGY, 2005.Link to Item
-
Chien, A. C., R. Zennadi, L. M. De Castro, and M. J. Telen. “Adhesive characteristics of hemoglobin SC red blood cells.” In Blood, 106:23B-24B. AMER SOC HEMATOLOGY, 2005.Link to Item
-
De Castro, L. M., J. C. Jonassaint, and M. J. Telen. “Left sided heart dysfunction in sickle cell disease: Echocardiographic and genetic studies.” In Blood, 106:27A-27A. AMER SOC HEMATOLOGY, 2005.Link to Item
-
Fitzhugh, C., N. Lauder, J. Jonassaint, F. R. Gilliam, M. J. Telen, and L. M. De Castro. “Morbidity and associated sudden death in sickle cell disease.” In Blood, 106:661A-661A. AMER SOC HEMATOLOGY, 2005.Link to Item
-
Ko, M., L. M. De Castro, J. C. Jonassaint, M. Batchvarova, R. Zennadi, and M. J. Telen. “The relationship of plasma laminin levels to anemia and the effect of soluble laminin on sickle red cell adhesion in SCD.” In Blood, 106:657A-657A. AMER SOC HEMATOLOGY, 2005.Link to Item
-
Zennadi, R., B. J. Moeller, M. W. Dewhirst, and M. J. Telen. “Role of LW and AKAP79 in beta-adrenergic receptor signaling-induced sickle red blood cell adhesion.” In Blood, 106:889A-889A. AMER SOC HEMATOLOGY, 2005.Link to Item
-
Combs, M. R., R. S. Arney, D. H. Bennett, and M. J. Telen. “Delayed serological transfusion reactions and the gel test: A five year experience.” In Transfusion, 45:123A-123A. BLACKWELL PUBLISHING, 2005.Link to Item
-
Combs, M. R., R. S. Arney, S. W. Parrott, E. S. Wester, M. L. Olsson, and M. J. Telen. “Kidd antigen suppression and production of anti-Jk(a),-Jk3 in pregnancy: A case report.” In Transfusion, 45:5A-5A. BLACKWELL PUBLISHING, 2005.Link to Item
-
Combs, M. R., R. S. Arney, and M. J. Telen. “Comparison of gel and polyethylene glycol for the detection of alloantibodies associated with delayed serological transfusion reactions.” In Transfusion, 45:138A-139A. BLACKWELL PUBLISHING, 2005.Link to Item
-
Ashley-Koch, Allison E., Laura De Castro, Felicia Lennon-Graham, Jude Jonassaint, Terry L. Jackson, Jennifer Price, Jason Galloway, et al. “Genetic Polymorphisms Associated with Risk for Pulmonary Hypertension and Proteinuria in Sickle Cell Disease.” In Blood, 104:1668–1668. American Society of Hematology, 2004. https://doi.org/10.1182/blood.v104.11.1668.1668.Full Text
-
De Castro, Laura M., Jude C. Jonassaint, Felicia L. Graham, Allison Ashley-koch, and Marilyn J. Telen. “Pulmonary Hypertension in SS, SC and Sβ Thalassemia: Prevalence, Associated Clinical Syndromes, and Mortality.” In Blood, 104:1663–1663. American Society of Hematology, 2004. https://doi.org/10.1182/blood.v104.11.1663.1663.Full Text
-
Eyler, Christine E., Terry L. Jackson, Laura M. De Castro, Rahima Zennadi, Jeffery M. Vance, Allison Ashley-Koch, and Marilyn J. Telen. “Effects of Single Nucleotide Polymorphisms of the β2 Adrenergic Receptor and of Adenylate Cyclase on Sickle Red Cell Adhesion to Laminin.” In Blood, 104:3565–3565. American Society of Hematology, 2004. https://doi.org/10.1182/blood.v104.11.3565.3565.Full Text
-
Zennadi, Rahima, Benjamin J. Moeller, Erin J. Whalen, Mark W. Dewhirst, and Marilyn J. Telen. “Epinephrine-Induced Sickle Red Cell Adhesion and Vaso-Occlusion In Vivo Is Inhibited by the β-Adrenoceptor Blocker Propranolol.” In Blood, 104:364–364. American Society of Hematology, 2004. https://doi.org/10.1182/blood.v104.11.364.364.Full Text
-
Zennadi, Rahima, Erin J. Whalen, and Marilyn J. Telen. “Protein Kinases Associated with Activation of Sickle Red Blood Cell Adhesion.” In Blood, 104:3567–3567. American Society of Hematology, 2004. https://doi.org/10.1182/blood.v104.11.3567.3567.Full Text
-
De Castro, L. M., J. C. Jonassaint, S. Rainey, R. Motley, S. Jones, J. Galloway, L. Zhang, et al. “B-CAM/LU polymorphisms: Effect on sickle cell disease outcomes and cell adhesion.” In Blood, 102:28B-28B. AMER SOC HEMATOLOGY, 2003.Link to Item
-
Hines, P. C., C. Okafor, Q. Zen, M. J. Telen, K. I. Ataga, E. P. Orringer, and L. V. Parise. “Sickle RBCs form microaggregates in autologous plasma following epinephrine stimulation: A role for endogenous, soluble laminin.” In Blood, 102:82A-82A. AMER SOC HEMATOLOGY, 2003.Link to Item
-
Murphy, M. M., A. Evans, M. A. Zayed, J. E. Brittain, E. P. Orringer, K. I. Ataga, C. E. Eyler, M. J. Telen, and L. V. Parise. “The small GTPase rapl activates BCAM/LU-dependent but not alpha 4 beta l-dependent adhesion in sickle red blood cells: Evidence for divergent adhesive pathways.” In Blood, 102:82A-82A. AMER SOC HEMATOLOGY, 2003.Link to Item
-
Telen, M. J., A. E. Ashley-Koch, L. Zhang, J. Jonassaint, S. Rainey, R. Motley, S. Jones, et al. “Examination of a VCAM1 polymorphism as a risk modifier for clinical outcomes in sickle cell disease.” In Blood, 102:29B-29B. AMER SOC HEMATOLOGY, 2003.Link to Item
-
Zennadi, R., B. J. Moeller, Q. Zen, M. W. Dewhirst, and M. J. Telen. “In vitro exposure to epinephrine causes in vivo adhesion of human sickle red blood cells to vascular endothelium in nude mice: A new model for studying vaso-occlusion.” In Blood, 102:261A-261A. AMER SOC HEMATOLOGY, 2003.Link to Item
-
Zennadi, R., J. P. Cartron, and M. J. Telen. “cAMP-dependent activation of sickle red blood cell adhesion is associated with LW serine and tyrosine phosphorylation.” In Blood, 102:263A-263A. AMER SOC HEMATOLOGY, 2003.Link to Item
-
De Castro, L. M., J. Jonassaint, S. Rainey, R. Motley, S. Jones, J. Galloway, L. Zhang, et al. “B-CAM/LU modifies sickle cell disease severity.” In American Journal of Human Genetics, 73:569–569. UNIV CHICAGO PRESS, 2003.Link to Item
-
Telen, M. J., A. E. Ashley-Koch, L. Zhang, J. Jonassaint, S. Rainey, R. Motley, S. Jones, et al. “Examination of VCAM1 as a modulator of stroke risk in sickle cell disease.” In American Journal of Human Genetics, 73:569–569. UNIV CHICAGO PRESS, 2003.Link to Item
-
Combs, M. R., J. Allen, R. Buckley, and M. J. Telen. “Recipient alloimmunization against bone marrow donor red cells in an infant with severe combined immunodeficiency (SCID).” In Transfusion, 43:52A-52A. AMER ASSOC BLOOD BANKS, 2003.Link to Item
-
De Castro, L. M., L. Palmer, J. C. Jonassaint, and M. J. Telen. “Relationship of sickle red blood cell laminin binding to disease activity.” In Blood, 100:450A-451A. AMER SOC HEMATOLOGY, 2002.Link to Item
-
Isola, L. M., J. N. Chao, S. Weinberg, S. M. Fruchtman, G. Atweh, S. McCune, M. J. Telen, et al. “Donor chimerism after T-Cell depleted (TCD)-Non-Myeloablative allogeneic SCT (NST) in hemoglobinopathies.” In Blood, 100:401B-402B. AMER SOC HEMATOLOGY, 2002.Link to Item
-
Qin, Z., J. Cho, R. E. Lekwauwa, R. Zennadi, and M. J. Telen. “B-CAM/LU mediates laminin-independent cell-cell adhesion under both static and flow conditions.” In Blood, 100:451A-451A. AMER SOC HEMATOLOGY, 2002.Link to Item
-
Zennadi, R., P. M. Hines, L. M. De Castro, J. P. Cartron, L. V. Parise, and M. J. Telen. “Modulation by epinephrine of PKA-dependent signaling pathways in sickle red blood cells induces activation of LW binding to endothelial cell alpha v beta 3 integrin.” In Blood, 100:118A-118A. AMER SOC HEMATOLOGY, 2002.Link to Item
-
Combs, M. R., C. M. Decastro, and M. J. Telen. “Delayed transfusion reactions and allo- and autoantibody production in sickle cell patients following erythrocytapheresis.” In Transfusion, 42:26S-26S. AMER ASSOC BLOOD BANKS, 2002.Link to Item
-
TELEN, M. J. “NEW AND EVOLVING TECHNIQUES FOR ANTIBODY AND ANTIGEN IDENTIFICATION.” In Alloimmunity: 1993 and Beyond, edited by S. T. Nance, 117–39. AMER ASSOC BLOOD BANKS, 1993.Link to Item
-
-
- Teaching & Mentoring
-
Recent Courses
Some information on this profile has been compiled automatically from Duke databases and external sources. (Our About page explains how this works.) If you see a problem with the information, please write to Scholars@Duke and let us know. We will reply promptly.